KR20230116069A - liquid skin cleanser composition - Google Patents
liquid skin cleanser composition Download PDFInfo
- Publication number
- KR20230116069A KR20230116069A KR1020237024676A KR20237024676A KR20230116069A KR 20230116069 A KR20230116069 A KR 20230116069A KR 1020237024676 A KR1020237024676 A KR 1020237024676A KR 20237024676 A KR20237024676 A KR 20237024676A KR 20230116069 A KR20230116069 A KR 20230116069A
- Authority
- KR
- South Korea
- Prior art keywords
- mass
- component
- content
- cleanser composition
- skin
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 75
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 229920006317 cationic polymer Polymers 0.000 claims abstract description 17
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 15
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 claims abstract description 15
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 15
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims abstract description 14
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims abstract description 14
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 claims abstract description 13
- NPSSWQJHYLDCNV-UHFFFAOYSA-N prop-2-enoic acid;hydrochloride Chemical compound Cl.OC(=O)C=C NPSSWQJHYLDCNV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 12
- 229920000642 polymer Polymers 0.000 claims abstract description 7
- 229920001577 copolymer Polymers 0.000 claims description 16
- 239000003599 detergent Substances 0.000 claims 1
- -1 fatty acid salt Chemical class 0.000 description 67
- 238000001035 drying Methods 0.000 description 47
- 239000006260 foam Substances 0.000 description 35
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 33
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 30
- 235000014113 dietary fatty acids Nutrition 0.000 description 30
- 239000000194 fatty acid Substances 0.000 description 30
- 229930195729 fatty acid Natural products 0.000 description 30
- 230000014759 maintenance of location Effects 0.000 description 24
- 230000037394 skin elasticity Effects 0.000 description 22
- 150000004665 fatty acids Chemical class 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 235000011118 potassium hydroxide Nutrition 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000344 soap Substances 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 239000003240 coconut oil Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 229940073490 sodium glutamate Drugs 0.000 description 9
- 239000004677 Nylon Substances 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 230000001771 impaired effect Effects 0.000 description 8
- 229920001778 nylon Polymers 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 229940114926 stearate Drugs 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 229920000742 Cotton Polymers 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- 229920006322 acrylamide copolymer Polymers 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- FJWSMXKFXFFEPV-UHFFFAOYSA-N prop-2-enamide;hydrochloride Chemical compound Cl.NC(=O)C=C FJWSMXKFXFFEPV-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- KTCCLEVCNRHWQL-UHFFFAOYSA-N 3-(2-oxotridecylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)CNCCC(O)=O KTCCLEVCNRHWQL-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 206010050637 Skin tightness Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 238000005187 foaming Methods 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000013065 commercial product Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 229940070765 laurate Drugs 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229940114930 potassium stearate Drugs 0.000 description 3
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 3
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 3
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- NSHPEBWOVULKBI-UHFFFAOYSA-M sodium;1-dodecoxydodecane;acetate Chemical compound [Na+].CC([O-])=O.CCCCCCCCCCCCOCCCCCCCCCCCC NSHPEBWOVULKBI-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- AOLMPVPUFVWGPN-UHFFFAOYSA-N diazanium;1-dodecoxydodecane;sulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC AOLMPVPUFVWGPN-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 description 2
- 239000004317 sodium nitrate Substances 0.000 description 2
- 235000010344 sodium nitrate Nutrition 0.000 description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 229920003176 water-insoluble polymer Polymers 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- SFPUOSSXJIXIQU-UHFFFAOYSA-N (2-oxopentadecylamino) acetate;sodium Chemical compound [Na].CCCCCCCCCCCCCC(=O)CNOC(C)=O SFPUOSSXJIXIQU-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- BQJLEQAXRYBKPQ-UHFFFAOYSA-N 2-amino-2-methylpropane-1,1-diol Chemical compound CC(C)(N)C(O)O BQJLEQAXRYBKPQ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010054404 Adenylyl-sulfate kinase Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102100039024 Sphingosine kinase 1 Human genes 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- JUGFVVYVVZCPIT-UHFFFAOYSA-N [K].CCCCCCCCCCCC(=O)N(C)CCC(O)=O Chemical compound [K].CCCCCCCCCCCC(=O)N(C)CCC(O)=O JUGFVVYVVZCPIT-UHFFFAOYSA-N 0.000 description 1
- SNYHHRATSHXAPP-UHFFFAOYSA-N [Na].CCCCCCCCCCCCCC(=O)N(CC(O)=O)CCC(O)=O Chemical compound [Na].CCCCCCCCCCCCCC(=O)N(CC(O)=O)CCC(O)=O SNYHHRATSHXAPP-UHFFFAOYSA-N 0.000 description 1
- OBHAIFOMZXGPIA-DFWYDOINSA-N [Na].CN[C@@H](C)C(O)=O Chemical compound [Na].CN[C@@H](C)C(O)=O OBHAIFOMZXGPIA-DFWYDOINSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- ZITKDVFRMRXIJQ-UHFFFAOYSA-N dodecane-1,2-diol Chemical compound CCCCCCCCCCC(O)CO ZITKDVFRMRXIJQ-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940049256 laureth-4 carboxylic acid Drugs 0.000 description 1
- ILRSCQWREDREME-UHFFFAOYSA-N lauric acid amide propyl betaine Natural products CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229940045790 sodium lauryl glycol carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- UIGBPGNEWMRLGK-UHFFFAOYSA-M sodium;2-(2-hydroxydodecoxy)acetate Chemical compound [Na+].CCCCCCCCCCC(O)COCC([O-])=O UIGBPGNEWMRLGK-UHFFFAOYSA-M 0.000 description 1
- LOBXNKKFDKXXQW-UHFFFAOYSA-M sodium;3-[dodecanoyl(methyl)amino]propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCC([O-])=O LOBXNKKFDKXXQW-UHFFFAOYSA-M 0.000 description 1
- ISONEALTCIBOKV-UHFFFAOYSA-M sodium;3-[methyl(tetradecanoyl)amino]propanoate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CCC([O-])=O ISONEALTCIBOKV-UHFFFAOYSA-M 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
(A)(a1)팔미트산염 및 (a2)스테아르산염으로부터 선택되는 적어도 1종을 함유하는 음이온성 계면활성제와, (B)염화디메틸디알릴암모늄 중합체 및 염화디메틸디알릴암모늄-아크릴산 공중합체로부터 선택되는 적어도 1종의 양이온성 폴리머와, (C)평균 분자량이 190∼630인 폴리에틸렌글리콜을 함유하고, 질량비[(A)/(C)]가 15∼100이며, 포머 용기에 충전되어서 이루어지는 액체 피부 세정제 조성물이다.(A) (a1) an anionic surfactant containing at least one selected from palmitate and (a2) stearate, and (B) dimethyldiallylammonium chloride polymer and dimethyldiallylammonium chloride-acrylic acid copolymer A liquid comprising at least one selected cationic polymer and (C) polyethylene glycol having an average molecular weight of 190 to 630, having a mass ratio [(A)/(C)] of 15 to 100, and filled into a former container. It is a skin cleanser composition.
Description
본 발명은 액체 피부 세정제 조성물에 관한 것이다.The present invention relates to liquid skin cleanser compositions.
종래부터, 핸드 소프나 바디 소프 등의 액체 피부 세정제 조성물에는 거품 유지 등의 거품성능이 양호한 것, 및 헹굼시의 피부에 매끄러움을 부여하는 것, 타올 드라이후의 피부에 탄력을 부여하는 것, 타올 드라이후의 피부에 당김감을 느끼지 않는 것 등의 사용감이 양호한 것이 요구되고 있다. 그러나, 나일론 타올이나 면 타올 등의 세정 용구를 사용해서 세정하는 소비자가 대부분을 차지하는 것에 대해, 최근 수요가 높아지고 있는 거품으로 나오는 타입의 바디 소프를, 세정 용구를 사용해서 사용하면, 거품 유지와 저온 안정성의 양립을 만족할 수 있는 것은 아니다라는 문제가 있었다.Conventionally, in liquid skin cleanser compositions such as hand soap and body soap, those with good foaming performance such as foam retention, those that give smoothness to the skin during rinsing, those that give elasticity to the skin after towel drying, and towels It is desired to have a good feeling of use, such as not feeling a tightening feeling on the skin after drying. However, compared to the majority of consumers washing with cleaning tools such as nylon towels and cotton towels, when using the foaming body soap, which has recently increased in demand, using cleaning tools, foam retention and low temperature There was a problem that compatibility of stability could not be satisfied.
양호한 사용감을 부여하기 위해서, 예를 들면, 지방산염과 염화디메틸디알릴암모늄으로부터 유래하는 구조단위를 갖는 양이온성 폴리머를 함유하는 액체 피부 세정제 조성물이 제안되어 있다(예를 들면, 특허문헌 1, 2 등 참조). 그러나, 상기 제안의 액체 피부 세정제 조성물은 나일론 타올이나 면 타올 등의 세정 용구를 사용해서 거품을 냈을 때의 거품 유지, 타올 드라이후의 피부의 탄력, 및 저온 안정성에 대해서 만족할 수 있는 것은 아니다라는 문제가 있었다.In order to impart a good feeling of use, for example, a liquid skin cleanser composition containing a cationic polymer having a fatty acid salt and a structural unit derived from dimethyldiallylammonium chloride has been proposed (for example, Patent Documents 1 and 2 see etc.). However, the liquid skin cleanser composition of the above proposal is not satisfactory for foam retention when lathering using cleaning tools such as nylon towels and cotton towels, skin elasticity after towel drying, and low-temperature stability. there was
또한, 액체 피부 세정제 조성물의 거품 유지를 좋게 하기 위해서, 예를 들면, 폴리옥시에틸렌알킬에테르나 지방산 모노에탄올아미드 등의 비이온 계면활성제를 함유하는 액체 피부 세정제 조성물이 제안되어 있다(예를 들면, 특허문헌 3 참조). 그러나, 상기 제안의 액체 피부 세정제 조성물은 타올 드라이후의 피부의 탄력 및 저온 안정성에 대해서 만족할 수 있는 것은 아니다라는 문제가 있었다.In addition, in order to improve the foam retention of the liquid skin cleanser composition, for example, a liquid skin cleanser composition containing a nonionic surfactant such as polyoxyethylene alkyl ether or fatty acid monoethanolamide has been proposed (e.g., See Patent Document 3). However, there was a problem that the liquid skin cleanser composition of the above proposal was not satisfactory for skin elasticity and low-temperature stability after towel drying.
액체 피부 세정제 조성물의 거품 유지를 좋게 하기 위해서는 팔미트산이나 스테아르산 등의 장쇄 지방산을 보다 많이 첨가하는 것이 일반적으로 알려져 있지만, 액체 피부 세정제 조성물 중의 장쇄 지방산의 비율을 올리면, 저온에 있어서 지방산이 석출되어 투명한 외관을 유지할 수 없게 되는 것, 타올 드라이후에 피부의 탄력이 저감하는 것 등의 문제가 있었다.In order to improve the foam retention of the liquid skin cleanser composition, it is generally known to add more long-chain fatty acids such as palmitic acid and stearic acid. However, when the ratio of long-chain fatty acids in the liquid skin cleanser composition is increased, fatty acids precipitate at low temperatures There were problems such as becoming unable to maintain a transparent appearance and reducing the elasticity of the skin after towel drying.
따라서, 나일론 타올이나 면 타올 등의 세정 용구를 사용해서 거품을 냈을 때의 거품 유지가 우수하고, 타올 드라이후의 피부에 당김감을 느끼지 않고, 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 탄력이 양호하며, 또한 저온 조건 하에 있어서도 지방산의 석출을 방지하여 투명한 외관을 유지할 수 있는 포머 용기에 충전되어서 이루어지는 액체 피부 세정제 조성물의 제공이 강하게 요구되고있는 것이 현상황이다.Therefore, it is excellent in foam retention when foaming using a cleaning tool such as a nylon towel or cotton towel, does not feel a tight feeling on the skin after towel drying, smoothness of the skin during rinsing, and elasticity of the skin after towel drying. The current situation is that the provision of a liquid skin cleanser composition filled in a foamer container capable of preventing precipitation of fatty acids and maintaining a transparent appearance even under low-temperature conditions is strongly desired.
본 발명은 종래에 있어서의 상기 여러 문제를 해결하여 이하의 목적을 달성하는 것을 과제로 한다. 즉, 본 발명은 거품 유지가 우수하고, 타올 드라이후의 피부에 당김감을 느끼지 않고, 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 탄력이 양호하며, 또한 저온 안정성이 우수한 액체 피부 세정제 조성물을 제공하는 것을 목적으로 한다.The present invention solves the above problems in the prior art and makes it a subject to achieve the following objects. That is, the present invention provides a liquid skin cleanser composition that is excellent in foam retention, does not feel tight on the skin after towel drying, has good skin smoothness during rinsing and good skin elasticity after towel drying, and has excellent low-temperature stability. intended to provide
본 발명자는 예의 검토를 행한 결과, (A)(a1)팔미트산염 및 (a2)스테아르산염으로부터 선택되는 적어도 1종을 함유하는 음이온성 계면활성제와, (B)염화디메틸디알릴암모늄 중합체 및 염화디메틸디알릴암모늄-아크릴산 공중합체로부터 선택되는 적어도 1종의 양이온성 폴리머와, (C)평균 분자량이 190∼630인 폴리에틸렌글리콜을 함유하고, 상기 (A)성분의 함유량이 10질량%∼25질량%이며, 상기 (B)성분의 염화디메틸디알릴암모늄-아크릴산 공중합체에 있어서의 염화디메틸디알릴암모늄으로부터 유래하는 구조단위의 몰비가 40몰% 이상이며, 상기 (C)성분의 함유량에 대한 상기 (A)성분의 함유량의 질량비[(A)/(C)]가 15∼100이며, 포머 용기에 충전되어서 이루어지는 액체 피부 세정제 조성물이 거품 유지가 우수하고, 타올 드라이후의 피부에 당김감을 느끼지 않고, 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 탄력이 양호하며, 또한 저온 안정성이 우수한 것을 찾아냈다.As a result of intensive examination, the present inventors have found (A) (a1) an anionic surfactant containing at least one selected from palmitate and (a2) stearate; (B) a dimethyldiallylammonium chloride polymer and a chloride At least one type of cationic polymer selected from dimethyldiallylammonium-acrylic acid copolymers and (C) polyethylene glycol having an average molecular weight of 190 to 630 are contained, and the content of the component (A) is 10% by mass to 25% by mass %, and the molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer of the component (B) is 40 mol% or more, and the above for the content of the component (C) The mass ratio [(A)/(C)] of the content of (A) component is 15 to 100, and the liquid skin cleanser composition filled in the foamer container has excellent foam retention and does not feel tight on the skin after towel drying. , the smoothness of the skin during rinsing and the elasticity of the skin after towel drying were good, and the low-temperature stability was found to be excellent.
본 발명은 본 발명자에 의한 상기 지견에 의거하는 것이며, 상기 과제를 해결하기 위한 수단으로서는 아래와 같다. 즉,This invention is based on the said knowledge by this inventor, and means for solving the said subject are as follows. in other words,
<1>(A)(a1)팔미트산염 및 (a2)스테아르산염으로부터 선택되는 적어도 1종을 함유하는 음이온성 계면활성제와,<1> (A) an anionic surfactant containing at least one selected from (a1) palmitate and (a2) stearate;
(B)염화디메틸디알릴암모늄 중합체 및 염화디메틸디알릴암모늄-아크릴산 공중합체로부터 선택되는 적어도 1종의 양이온성 폴리머와,(B) at least one cationic polymer selected from dimethyldiallylammonium chloride polymer and dimethyldiallylammonium chloride-acrylic acid copolymer;
(C)평균 분자량이 190∼630인 폴리에틸렌글리콜을 함유하고,(C) containing polyethylene glycol having an average molecular weight of 190 to 630;
상기 (A)성분의 함유량이 10질량%∼25질량%이며,The content of the component (A) is 10% by mass to 25% by mass,
상기 (B)성분의 염화디메틸디알릴암모늄-아크릴산 공중합체에 있어서의 염화디메틸디알릴암모늄으로부터 유래하는 구조단위의 몰비가 40몰% 이상이며,The molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer of the component (B) is 40 mol% or more,
상기 (C)성분의 함유량에 대한 상기 (A)성분의 함유량의 질량비[(A)/(C)]가 15∼100이며,The mass ratio of the content of the component (A) to the content of the component (C) [(A) / (C)] is 15 to 100,
포머 용기에 충전되어서 이루어지는 것을 특징으로 하는 액체 피부 세정제 조성물이다.It is a liquid skin cleanser composition characterized by being filled in a foamer container.
<2>(D)하기 일반식(1)으로 나타내어지는 공중합체를 더 함유하는 상기 <1>에 기재된 액체 피부 세정제 조성물이다.<2> (D) It is the liquid skin cleanser composition as described in said <1> which further contains the copolymer represented by following general formula (1).
단, 상기 일반식(1) 중, n, m, 및 z는 각 구조단위의 몰비(몰%)를 나타내고, n+m+z=100이며, 상기 n은 0∼34, 상기 m은 24∼31, 상기 z는 35∼76이다.However, in the general formula (1), n, m, and z represent the molar ratio (mol%) of each structural unit, n + m + z = 100, the n is 0 to 34, the m is 24 to 31, the z is 35 to 76.
<3>상기 (A)성분의 함유량에 대한 상기 (a1)팔미트산염과 상기 (a2)스테아르산염의 합계 함유량의 질량비[((a1)+(a2))/(A)]가 0.1∼0.5인 상기 <1> 내지 <2> 중 어느 하나에 기재된 액체 피부 세정제 조성물이다.<3> The mass ratio [((a1)+(a2))/(A)] of the total content of palmitate (a1) and stearate (a2) to the content of component (A) is 0.1 to 0.5 The liquid skin cleanser composition according to any one of <1> to <2>.
<4>상기 (B)성분의 함유량이 0.2질량%∼0.8질량%이며,<4> The content of the component (B) is 0.2% by mass to 0.8% by mass,
상기 (C)성분의 함유량이 0.2질량%∼0.8질량%이며,The content of the component (C) is 0.2% by mass to 0.8% by mass,
상기 (D)성분의 함유량이 0.05질량%∼0.3질량%The content of the said (D) component is 0.05 mass % - 0.3 mass %
인 상기 <1> 내지 <3> 중 어느 하나에 기재된 액체 피부 세정제 조성물이다.The liquid skin cleanser composition according to any one of <1> to <3>.
본 발명에 의하면, 종래에 있어서의 상기 여러 문제를 해결하여 상기 목적을 달성할 수 있고, 거품 유지가 우수하고, 타올 드라이후의 피부에 당김감을 느끼지 않고, 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 탄력이 양호하며, 또한 저온 안정성이 우수한 액체 피부 세정제 조성물을 제공할 수 있다.According to the present invention, the above objects can be achieved by solving the various problems in the prior art, the foam retention is excellent, the skin does not feel tight after towel drying, the skin smoothness during rinsing and after towel drying It is possible to provide a liquid skin cleanser composition having good skin elasticity and excellent low-temperature stability.
(액체 피부 세정제 조성물)(liquid skin cleanser composition)
본 발명의 액체 피부 세정제 조성물은(A)음이온성 계면활성제와, (B)양이온성 폴리머와, (C)폴리에틸렌글리콜을 함유하고, (D)공중합체를 더 함유하는 것이 바람직하고, 또한 필요에 따라서, 그 밖의 성분을 함유한다.The liquid skin cleanser composition of the present invention preferably contains (A) an anionic surfactant, (B) a cationic polymer, (C) polyethylene glycol, and (D) a copolymer. Therefore, it contains other components.
<(A)음이온성 계면활성제><(A) anionic surfactant>
상기 (A)성분으로서의 음이온성 계면활성제는 주로, 거품 유지를 향상시키기 위해서 함유된다.The anionic surfactant as the component (A) is mainly contained in order to improve foam retention.
또한, 본 명세서에 있어서 「거품 유지」란 세정 용구를 사용했을 때에 거품이 꺼지지 않고 유지되는 것을 의미한다. 상기 세정 용구로서는 피부의 세정에 사용되는 것이면, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 나일론 타올, 면 타올 등을 들 수 있다.In addition, in this specification, "bubble maintenance" means that foam is maintained without being blown out when a washing tool is used. The cleaning tool is not particularly limited as long as it is used for skin cleaning, and may be appropriately selected according to the purpose, and examples thereof include nylon towels and cotton towels.
상기 (A)성분의 음이온성 계면활성제는 (a1)팔미트산염(이하, 「(a1)성분」이라고 칭하는 일이 있다) 및 (a2)스테아르산염(이하, 「(a2)성분」이라고 칭하는 일이 있다)으로부터 선택되는 적어도 1종을 함유한다.The anionic surfactant of the component (A) is (a1) palmitate (hereinafter sometimes referred to as "component (a1)") and (a2) stearate (hereinafter referred to as "component (a2)") It contains at least one selected from).
상기 (A)성분의 음이온성 계면활성제는 상기 (a1)팔미트산염 및 상기 (a2)스테아르산염으로부터 선택되는 적어도 1종을 함유하는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 상기 (a1)성분 및 상기 (a2)성분 이외의 고급 지방산염, 폴리옥시에틸렌(POE)알킬에테르 황산염, 에테르카르복실산염, 아미노산계 계면활성제 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다. 이들 중에서도, 고급 지방산염, POE알킬에테르 황산염이 바람직하고, 고급 지방산염이 보다 바람직하다.The anionic surfactant of component (A) is not particularly limited as long as it contains at least one selected from the group consisting of palmitate (a1) and stearate (a2), and may be appropriately selected according to the purpose. Examples thereof include higher fatty acid salts other than the component (a1) and component (a2), polyoxyethylene (POE) alkyl ether sulfates, ether carboxylates, amino acid surfactants, and the like. These may be used individually by 1 type, and may use 2 or more types together. Among these, higher fatty acid salts and POE alkyl ether sulfates are preferred, and higher fatty acid salts are more preferred.
-고급 지방산염--Higher Fatty Acids-
상기 (A)성분 중의 상기 고급 지방산염으로서는 상기 (a1)팔미트산염 및 상기 (a2)스테아르산염으로부터 선택되는 적어도 1종을 함유하는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 라우르산염, 미리스틴산염 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다. 이들 중에서도, 거품 유지 및 타올 드라이후의 피부의 탄력의 점에서, 팔미트산염, 스테아르산염, 라우르산염, 및 미리스틴산염을 모두 포함하는 고급 지방산염이 바람직하다.The higher fatty acid salt in the component (A) is not particularly limited as long as it contains at least one selected from the (a1) palmitate salt and the (a2) stearic acid salt, and can be appropriately selected according to the purpose. For example, laurate, myristate, etc. are mentioned. These may be used individually by 1 type, and may use 2 or more types together. Among these, higher fatty acid salts containing all of palmitate, stearate, laurate, and myristic acid salt are preferable from the viewpoint of foam retention and skin elasticity after towel drying.
상기 고급 지방산염의 쌍이온으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 알칼리 금속염, 아민염, 아미노산염 등을 들 수 있다.The counter ion of the higher fatty acid salt is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include alkali metal salts, amine salts, and amino acid salts.
상기 알칼리 금속염으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 나트륨염, 칼륨염 등을 들 수 있다. The alkali metal salt is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include sodium salt and potassium salt.
상기 아민염으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 암모늄염; 모노에탄올아민염, 디에탄올아민염, 트리에탄올아민염, 2-아미노-2-메틸프로판올, 2-아미노-2-메틸프로판디올 등의 알칸올아민염 등을 들 수 있다.The amine salt is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include ammonium salts; Alkanolamine salts, such as a monoethanolamine salt, a diethanolamine salt, a triethanolamine salt, 2-amino-2-methylpropanol, and 2-amino-2-methylpropanediol, etc. are mentioned.
상기 아미노산염으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 리신염, 아르기닌염 등을 들 수 있다.The amino acid salt is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include lysine salts and arginine salts.
이들 중에서도, 알칼리 금속염이 바람직하고, 칼륨염이 특히 바람직하다.Among these, alkali metal salts are preferred, and potassium salts are particularly preferred.
상기 고급 지방산염은 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다.As the higher fatty acid salts, those synthesized appropriately may be used, or commercially available products may be used.
상기 고급 지방산염의 시판품으로서는 예를 들면, 상품명으로 논살 PK-1(팔미트산 칼륨, NOF CORPORATION제), 논살 SK-1(스테아르산 칼륨, NOF CORPORATION제), NIKKOL 라우르산 칼리 LK-120(라우르산 칼륨, 닛코케미칼즈 가부시키가이샤제), NIKKOL 미리스틴산 칼리 MK-140(미리스틴산 칼륨, 닛코케미칼즈 가부시키가이샤제), 타이소프 MNK-40(야자유 지방산 칼륨·미리스틴산 칼륨 배합 액체, 닛코케미칼즈 가부시키가이샤제) 등을 들 수 있다.Commercially available products of the higher fatty acid salts include, for example, Nonsal PK-1 (potassium palmitate, manufactured by NOF CORPORATION), Nonsal SK-1 (potassium stearate, manufactured by NOF CORPORATION), and NIKKOL potassium laurate LK-120 as trade names. (Potassium laurate, manufactured by Nikko Chemicals Co., Ltd.), NIKKOL potassium myristate MK-140 (potassium myristate, manufactured by Nikko Chemicals Co., Ltd.), TYSOF MNK-40 (coconut oil fatty acid potassium, myristin Acid potassium blending liquid, Nikko Chemicals Co., Ltd. make), etc. are mentioned.
상기 고급 지방산염은 고급 지방산염으로서 배합하는 것도 가능하지만, 고급 지방산과, 수산화 칼륨 등의 상기 쌍이온이 되는 염을 따로따로, 배합조 중에 첨가하고 중화 반응시켜서 고급 지방산염으로 해도 좋다.Although the higher fatty acid salt can be blended as a higher fatty acid salt, the higher fatty acid salt and a salt that becomes a counter ion such as potassium hydroxide may be separately added to a mixing tank and neutralized to form a higher fatty acid salt.
상기 고급 지방산염의 조제에 사용하는 상기 고급 지방산은 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다.As the higher fatty acid used for preparation of the higher fatty acid salt, an appropriately synthesized one may be used, or a commercial product may be used.
상기 고급 지방산의 시판품으로서는 예를 들면, 상품명으로 NAA(등록상표)-160(팔미트산, NOF CORPORATION제), NAA(등록상표)-180(스테아르산, NOF CORPORATION제), NAA(등록상표)-122(라우르산, NOF CORPORATION제), NAA(등록상표)-142(미리스틴산, NOF CORPORATION제) 등을 들 수 있다.Commercially available products of the above-mentioned higher fatty acids include, for example, NAA (registered trademark) -160 (palmitic acid, manufactured by NOF CORPORATION), NAA (registered trademark) -180 (stearic acid, manufactured by NOF CORPORATION), and NAA (registered trademark) as trade names. -122 (lauric acid, manufactured by NOF CORPORATION), NAA (registered trademark) -142 (myristic acid, manufactured by NOF CORPORATION), and the like.
상기 (a1)팔미트산염의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 액체 피부 세정제 조성물 전량에 대해서 1질량%∼10질량%가 바람직하고, 3질량%∼9질량%가 보다 바람직하다.The content of the above (a1) palmitate is not particularly limited and can be appropriately selected according to the purpose, but is preferably 1% by mass to 10% by mass, and more preferably 3% by mass to 9% by mass relative to the total amount of the liquid skin cleanser composition. desirable.
상기 (a2)스테아르산염의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼3질량%가 바람직하고, 0.2질량%∼1질량%가 보다 바람직하다.The content of the (a2) stearate is not particularly limited and can be appropriately selected according to the purpose, but is preferably 0.1% by mass to 3% by mass, and more preferably 0.2% by mass to 1% by mass, based on the total amount of the liquid skin cleanser composition. do.
상기 라우르산염의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 액체 피부 세정제 조성물 전량에 대해서 3질량%∼12질량%가 바람직하고, 7질량%∼10질량%가 보다 바람직하다.The content of the laurate is not particularly limited and can be appropriately selected according to the purpose, but is preferably 3% by mass to 12% by mass, and more preferably 7% by mass to 10% by mass with respect to the total amount of the liquid skin cleanser composition.
상기 미리스틴산염의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 액체 피부 세정제 조성물 전량에 대해서 3질량%∼14질량%가 바람직하고, 8질량%∼14질량%가 보다 바람직하다.The content of the myristate is not particularly limited and can be appropriately selected according to the purpose, but is preferably 3% by mass to 14% by mass, and more preferably 8% by mass to 14% by mass with respect to the total amount of the liquid skin cleanser composition.
-폴리옥시에틸렌알킬에테르 황산염--Polyoxyethylene alkyl ether sulfate-
상기 (A)성분 중의 상기 폴리옥시에틸렌알킬에테르 황산염으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 하기 일반식(A1)으로 나타내어지는 화합물 등을 들 수 있다. 상기 폴리옥시에틸렌알킬에테르 황산염은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.The polyoxyethylene alkyl ether sulfate in the component (A) is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include compounds represented by the following general formula (A1). The said polyoxyethylene alkyl ether sulfate may be used individually by 1 type, and may use 2 or more types together.
상기 일반식(A1) 중, R1은 알킬기를 나타내고, 상기 알킬기 부분의 탄소수로서는 10∼14가 바람직하다.In the general formula (A1), R 1 represents an alkyl group, and the number of carbon atoms in the alkyl group portion is preferably 10 to 14.
상기 일반식(A1) 중, n은 에틸렌옥사이드(E.O.)의 평균 부가 몰수를 나타내고, 상기 에틸렌옥사이드의 평균 부가 몰수로서는 1∼5가 바람직하다.In the general formula (A1), n represents the average number of added moles of ethylene oxide (E.O.), and the average number of added moles of ethylene oxide is preferably 1 to 5.
상기 일반식(A1) 중, X는 알칼리 금속, 또는 암모늄을 나타낸다. In the general formula (A1), X represents an alkali metal or ammonium.
상기 알칼리 금속으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 나트륨, 칼륨 등을 들 수 있다. The alkali metal is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include sodium and potassium.
상기 폴리옥시에틸렌알킬에테르 황산염의 구체예로서는 폴리옥시에틸렌(1)라우릴에테르 황산 나트륨, 폴리옥시에틸렌(2)라우릴에테르 황산 나트륨(별명:POE(2)라우레스 황산 나트륨), 폴리옥시에틸렌(3)라우릴에테르 황산 나트륨(별명:POE(3)라우레스 황산 나트륨), 폴리옥시에틸렌(4)라우릴에테르 황산 나트륨, 폴리옥시에틸렌(5)라우릴에테르 황산 나트륨, 폴리옥시에틸렌(3)알킬(C12,13)에테르 황산 나트륨, 폴리옥시에틸렌(2)라우릴에테르 황산 암모늄, 폴리옥시에틸렌(3)라우릴에테르 황산 암모늄 등을 들 수 있다.Specific examples of the polyoxyethylene alkyl ether sulfate include polyoxyethylene (1) sodium lauryl ether sulfate, polyoxyethylene (2) sodium lauryl ether sulfate (alias: POE (2) sodium laureth sulfate), polyoxyethylene ( 3) Sodium lauryl ether sulfate (alias: POE (3) sodium laureth sulfate), polyoxyethylene (4) sodium lauryl ether sulfate, polyoxyethylene (5) sodium lauryl ether sulfate, polyoxyethylene (3) Alkyl (C12,13) ether sodium sulfate, polyoxyethylene (2) lauryl ether ammonium sulfate, polyoxyethylene (3) lauryl ether ammonium sulfate, and the like.
또한, 상기 ( ) 내의 수치는 에틸렌옥사이드(E.O.)의 평균 부가 몰수(n)를 나타낸다.In addition, the numerical value in ( ) above represents the average number of added moles (n) of ethylene oxide (E.O.).
상기 폴리옥시에틸렌알킬에테르 황산염은 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다.As the polyoxyethylene alkyl ether sulfate, an appropriately synthesized one may be used, or a commercial item may be used.
상기 폴리옥시에틸렌알킬에테르 황산염의 시판품으로서는 예를 들면, 상품명으로 Texapon(텍사폰)(등록상표) N70(BASF Corp.제, 폴리옥시에틸렌(2)라우릴에테르 황산 나트륨), 시노린 SPE-1250(신니폰 리카 가부시키가이샤제, 폴리옥시에틸렌(2)라우릴에테르 황산 나트륨) 등을 들 수 있다.Commercially available products of the polyoxyethylene alkyl ether sulfate include, for example, Texapon (registered trademark) N70 (manufactured by BASF Corp., sodium polyoxyethylene (2) lauryl ether sulfate) and Shinorin SPE-1250 as trade names. (Shinnippon Rica Co., Ltd. product, polyoxyethylene (2) sodium lauryl ether sulfate) etc. are mentioned.
-에테르카르복실산염--Ether Carboxylate-
상기 (A)성분 중의 상기 에테르카르복실산염으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 하기 일반식(A2) 또는 (A3)으로 나타내어지는 화합물 등을 들 수 있다. 상기 에테르카르복실산염은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.The ether carboxylate in the component (A) is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include compounds represented by the following general formula (A2) or (A3). The said ether carboxylate may be used individually by 1 type, and may use 2 or more types together.
상기 일반식(A2) 및 (A3) 중, R2는 탄소수 5∼23의 직쇄 혹은 분기쇄의 알킬기 혹은 알케닐기, 또는 탄소수 5∼23의 직쇄 혹은 분기쇄의 알킬기 혹은 알케닐기로 치환된 페닐기를 나타내는, 상기 R2부분의 탄소수로서는 10∼14가 바람직하다.In the general formulas (A2) and (A3), R 2 represents a straight or branched alkyl or alkenyl group having 5 to 23 carbon atoms, or a phenyl group substituted with a straight or branched chain alkyl or alkenyl group having 5 to 23 carbon atoms. As carbon number of the said R <2> moiety shown, 10-14 are preferable.
상기 일반식(A2) 중, R3은 동일해도 달라도 좋고, 탄소수 2∼4의 알킬렌기를 나타내고, 탄소수 2가 바람직하다.In the general formula (A2), R 3 may be the same or different, and represents an alkylene group having 2 to 4 carbon atoms, and preferably has 2 carbon atoms.
상기 일반식(A2) 중, o는 1∼20의 알킬렌옥사이드의 평균 부가 몰수를 나타내고, 상기 알킬렌옥사이드의 평균 부가 몰수로서는 1∼5가 바람직하다.In the general formula (A2), o represents the average number of added moles of 1 to 20 alkylene oxides, and the number of average added moles of the alkylene oxides is preferably 1 to 5.
상기 일반식(A2) 및 (A3) 중, M1은 수소원자, 알칼리 금속, 알칼리 토류 금속, 암모늄, 또는 염기성 아미노산을 나타낸다.In the general formulas (A2) and (A3), M 1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.
상기 일반식(A2) 또는 (A3)으로 나타내어지는 에테르카르복실산염의 구체예로서는 폴리옥시에틸렌(3)라우릴에테르 아세트산 나트륨, 폴리옥시에틸렌(4)라우릴에테르 아세트산 칼륨, 라우릴글리콜 아세트산 나트륨 등을 들 수 있다. Specific examples of the ether carboxylate represented by the general formula (A2) or (A3) include polyoxyethylene (3) sodium lauryl ether acetate, polyoxyethylene (4) potassium lauryl ether acetate, and sodium lauryl glycol acetate. can be heard
또한, 상기 ( ) 내의 수치는 알킬렌옥사이드의 평균 부가 몰수(o)를 나타낸다.In addition, the numerical value in the above ( ) represents the average added mole number (o) of alkylene oxide.
상기 에테르카르복실산염은 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다.As the ether carboxylate, an appropriately synthesized one may be used, or a commercial product may be used.
상기 에테르카르복실산염의 시판품으로서는 예를 들면, 상품명으로 에나디콜EC-30(라이온 스페셜티 케미칼즈 가부시키가이샤제, 폴리옥시에틸렌(3)라우릴에테르 아세트산 나트륨), 뷰라이트 LCA-25F(폴리옥시에틸렌(3)라우릴에테르 아세트산 나트륨), 뷰라이트 LCA-30D(폴리옥시에틸렌(3)라우릴에테르 아세트산 나트륨), 뷰라이트 LCA-H(폴리옥시에틸렌(4)라우릴에테르 아세트산), 뷰라이트 LCA-25NH(라우레스-4카르복실산), 뷰라이트 SHAA(라우릴글리콜 카르복실산 나트륨), 뷰라이트 LCA(폴리옥시에틸렌(3)라우릴에테르 아세트산 나트륨)(이상, 산요 카세이 고교 가부시키가이샤제), 카오아키포 RLM-45NV(폴리옥시에틸렌(4.5)라우릴에테르 아세트산 나트륨), 카오아키포 RLM-100NV(폴리옥시에틸렌(10)라우릴에테르 아세트산 나트륨)(이상, 카오 가부시키가이샤제) 등을 들 수 있다.As a commercial product of the said ether carboxylate, for example, as a trade name, Enadicol EC-30 (made by Lion Specialty Chemicals Co., Ltd., polyoxyethylene (3) lauryl ether sodium acetate), Beurite LCA-25F (Polyoxy Ethylene (3) Lauryl Ether Sodium Acetate), Beurite LCA-30D (Polyoxyethylene (3) Lauryl Ether Sodium Acetate), Beurite LCA-H (Polyoxyethylene (4) Lauryl Ether Acetic Acid), Beurite LCA-25NH (laureth-4carboxylic acid), Beurite SHAA (sodium lauryl glycol carboxylate), Beurite LCA (sodium polyoxyethylene (3) lauryl ether acetate) (above, Sanyo Kasei Kogyo Co., Ltd.) Kaokipo RLM-45NV (sodium polyoxyethylene (4.5) lauryl ether acetate), Kaoakipo RLM-100NV (polyoxyethylene (10) sodium lauryl ether acetate) (above, Kao Co., Ltd.) ) and the like.
또한, 상기 ( ) 내의 수치는 알킬렌옥사이드의 평균 부가 몰수(o)를 나타낸다.In addition, the numerical value in the above ( ) represents the average added mole number (o) of alkylene oxide.
-아미노산계 계면활성제--Amino acid surfactant-
상기 (A)성분 중의 상기 아미노산계 계면활성제로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 하기 일반식(A4)으로 나타내어지는 화합물 등을 들 수 있다. 상기 아미노산계 계면활성제는 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.The amino acid-based surfactant in the component (A) is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include compounds represented by the following general formula (A4). The above amino acid surfactants may be used alone or in combination of two or more.
상기 일반식(A4) 중, R4는 탄소수 5∼23의 직쇄 혹은 분기쇄의 알킬기 혹은 알케닐기, 또는 탄소수 5∼23의 직쇄 혹은 분기쇄의 알킬기 혹은 알케닐기로 치환된 페닐기를 나타낸다. 상기 R4부분의 탄소수로서는 8∼18이 바람직하다.In the general formula (A4), R 4 represents a straight-chain or branched alkyl or alkenyl group having 5 to 23 carbon atoms or a phenyl group substituted with a linear or branched-chain alkyl or alkenyl group having 5 to 23 carbon atoms. As carbon number of the said R <4> moiety, 8-18 are preferable.
상기 일반식(A4) 중, R5는 수소원자 또는 탄소수 1∼3의 알킬기를 나타낸다.In the general formula (A4), R 5 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
상기 일반식(A4) 중, R6 및 R7은 동일해도 달라도 좋고, 수소원자 또는 -(CH2)m-COOM2를 나타낸다.In the general formula (A4), R 6 and R 7 may be the same or different and represent a hydrogen atom or -(CH 2 ) m -COOM 2 .
상기 일반식(A4) 중, m 및 n은 동일해도 달라도 좋고, 0∼20의 수를 나타낸다.In the above general formula (A4), m and n may be the same or different and represent a number from 0 to 20.
상기 일반식(A4) 중, M1 및 M2는 동일해도 달라도 좋고, 수소원자, 알칼리 금속, 알칼리 토류 금속, 암모늄, 또는 염기성 아미노산을 나타낸다.In the general formula (A4), M 1 and M 2 may be the same or different and represent a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.
상기 아미노산계 계면활성제의 친수부의 아미노산 구조로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 글리신, 글루탐산, 메틸알라닌이 바람직하다.The amino acid structure of the hydrophilic portion of the amino acid surfactant is not particularly limited and can be appropriately selected according to the purpose, but glycine, glutamic acid, and methylalanine are preferable.
상기 일반식(A4)으로 나타내어지는 아미노산계 계면활성제의 구체예로서는 N-코코일-글리신칼륨(N-야자유 지방산 아실글리신칼륨) 등의 N-아실-글리신 및 그 염; N-미리스토일-N-카르복시에틸-글리신나트륨 등의 N-아실-N-카르복시에틸-글리신 및 그 염; N-미리스토일-L-글루탐산 나트륨, N-미리스토일-L-글루탐산 칼륨, N-야자유 지방산 아실-L-글루탐산 칼륨, N-팜 지방산 아실-L-글루탐산 나트륨, N-스테아로일-L-글루탐산 나트륨 등의 N-아실글루탐산 및 그 염; N-라우로일-N-메틸-β-알라닌칼륨 등을 들 수 있다.Specific examples of the amino acid-based surfactant represented by the general formula (A4) include N-acyl-glycine and salts thereof such as N-cocoyl-glycine potassium (N-coconut oil fatty acid acylglycine potassium); N-acyl-N-carboxyethyl-glycine and its salts, such as sodium N-myristoyl-N-carboxyethyl-glycine; N-myristoyl-L-sodium glutamate, N-myristoyl-L-potassium glutamate, N-palm fatty acid acyl-L-potassium glutamate, N-palm fatty acid acyl-L-sodium glutamate, N-stearoyl- N-acylglutamic acids such as sodium L-glutamate and salts thereof; and N-lauroyl-N-methyl-β-alanine potassium.
상기 아미노산계 계면활성제는 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다.As the amino acid-based surfactant, those synthesized appropriately may be used, or commercially available products may be used.
상기 아미노산계 계면활성제의 시판품으로서는 예를 들면, 상품명으로 아미라이트(등록상표) GCK-11(N-야자유 지방산 아실글리신칼륨), 아미라이트(등록상표) GCK-12K(N-야자유 지방산 아실글리신칼륨), 아미라이트(등록상표) GCS-12K(N-야자유 지방산 아실글리신나트륨), 아미라이트(등록상표) GCS-11(N-야자유 지방산 아실글리신나트륨), 아미소프트(등록상표) CS-11(N-미리스토일-L-글루탐산 나트륨), 아미소프트(등록상표) CS-22(N-야자유 지방산 아실-L-글루탐산 나트륨), 아미소프트(등록상표) LS-11(N-라우로일-L-글루탐산 나트륨), 아미소프트(등록상표) MS-11(N-미리스토일-L-글루탐산 나트륨), 아미소프트(등록상표) HS-11P(N-스테아로일-L-글루탐산 나트륨), 아미소프트(등록상표) HS-11P(F)(N-스테아로일-L-글루탐산 나트륨), 아미소프트(등록상표) HS21(N-스테아로일-L-글루탐산 디나트륨), 아미라이트(등록상표) ACS-12(코코일알라닌나트륨)(이상, 아지노모토헬씨서플라이 가부시키가이샤제), 아미노서팩트(등록상표) AMMS-P1(N-미리스토일-L-글루탐산 나트륨)(Asahi Kasei Chemicals Corporation제), NIKKOL 살코시네이트 MN(미리스토일메틸아미노 아세트산 나트륨), NIKKOL 아라니네이트 LN-30(라우로일메틸-β-알라닌나트륨)(이상, 닛코케미칼즈 가부시키가이샤제), 아라논 ACE(야자유 지방산 메틸알라닌나트륨), 아라논 AME(미리스토일메틸-β-알라닌나트륨), 아라논 ALE(라우로일메틸-β-알라닌나트륨)(이상, 가와켄화인케미칼 가부시키가이샤제), 에나디콜 L-30AN(라우로일메틸-β-알라닌나트륨)(라이온 스페셜티 케미칼즈 가부시키가이샤제), 소프틸트 AT-L(라우로일메틸-β-알라닌나트륨)(NOF CORPORATION제) 등을 들 수 있다.Examples of commercially available products of the amino acid-based surfactant include Amylite (registered trademark) GCK-11 (N-coconut oil fatty acid acylglycine potassium) and Amirite (registered trademark) GCK-12K (N-coconut oil fatty acid acylglycine potassium) as trade names. ), Amirite (registered trademark) GCS-12K (sodium acylglycine of N-coconut oil fatty acid), Amirite (registered trademark) GCS-11 (sodium acylglycine of N-coconut oil fatty acid), Amisoft (registered trademark) CS-11 ( N-myristoyl-L-sodium glutamate), Amisoft (registered trademark) CS-22 (N-coconut oil fatty acid acyl-L-sodium glutamate), Amisoft (registered trademark) LS-11 (N-lauroyl- L-sodium glutamate), Amisoft (registered trademark) MS-11 (N-myristoyl-L-sodium glutamate), Amisoft (registered trademark) HS-11P (N-stearoyl-L-sodium glutamate), Amisoft (registered trademark) HS-11P(F) (N-stearoyl-L-sodium glutamate), Amisoft (registered trademark) HS21 (N-stearoyl-L-glutamate disodium), Amylight (registered trademark) Trademark) ACS-12 (cocoylalanine sodium) (above, manufactured by Ajinomoto Healthy Supply Co., Ltd.), Aminosurfact (registered trademark) AMMS-P1 (N-myristoyl-L-sodium glutamate) (Asahi Kasei Chemicals Corporation) agent), NIKKOL salcosinate MN (sodium myristoylmethylamino acetate), NIKKOL alaninate LN-30 (sodium lauroylmethyl-β-alanine) (above, manufactured by Nikko Chemicals Co., Ltd.), aranone ACE (coconut oil fatty acid sodium methylalanine), Aranone AME (sodium myristoylmethyl-β-alanine), Aranone ALE (sodium lauroylmethyl-β-alanine) (above, manufactured by Kawa Ken Fine Chemical Co., Ltd.) , Enadicol L-30AN (sodium lauroylmethyl-β-alanine) (manufactured by Lion Specialty Chemicals Co., Ltd.), Softilt AT-L (sodium lauroylmethyl-β-alanine) (manufactured by NOF Corporation), etc. can be heard
상기 (A)성분의 음이온성 계면활성제의 함유량은 거품 유지, 타올 드라이후의 피부의 탄력, 및 저온 안정성의 점에서, 액체 피부 세정제 조성물 전량에 대해서 10질량%∼25질량%이지만, 12질량%∼20질량%가 바람직하다. 상기 (A)성분의 함유량이 10질량% 미만이면, 거품 유지가 불충분하게 되고, 25질량%를 초과하면, 타올 드라이후의 피부의 탄력 및 저온 안정 성감이 불충분하게 된다.The content of the anionic surfactant in the component (A) is 10% by mass to 25% by mass with respect to the total amount of the liquid skin cleanser composition in terms of foam retention, skin elasticity after towel drying, and low-temperature stability, but 12% by mass -20% by mass is preferred. If the content of the component (A) is less than 10% by mass, foam retention becomes insufficient, and if it exceeds 25% by mass, elasticity of the skin after towel drying and stability at low temperatures become insufficient.
또한, 상기 (A)성분의 함유량에 대한 상기 (a1)팔미트산염과 상기 (a2)스테아르산염의 합계 함유량의 질량비[((a1)+(a2))/(A)]로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 거품 유지, 타올 드라이후의 피부의 탄력, 및 저온 안정성의 점에서, 0.1∼0.5가 바람직하고, 0.15∼0.3이 보다 바람직하다. 상기 [((a1)+(a2))/(A)]가 0.1 이상이면, 거품 유지가 양호하며, 0.5 이하이면, 타올 드라이후의 피부의 탄력 및 저온 안정성이 양호하다.In addition, the mass ratio [((a1)+(a2))/(A)] of the total content of the palmitate (a1) and the stearate (a2) to the content of the component (A) is not particularly limited. , can be appropriately selected depending on the purpose, but is preferably 0.1 to 0.5, and more preferably 0.15 to 0.3 from the viewpoints of foam retention, skin elasticity after towel drying, and low-temperature stability. When [((a1)+(a2))/(A)] is 0.1 or more, foam retention is good, and when it is 0.5 or less, skin elasticity and low-temperature stability after towel drying are good.
<(B)양이온성 폴리머><(B) cationic polymer>
상기 (B)성분으로서의 양이온성 폴리머는 염화디메틸디알릴암모늄 중합체 및 염화디메틸디알릴암모늄-아크릴산 공중합체로부터 선택되는 적어도 1종이며, 주로, 타올 드라이후의 피부의 탄력 및 헹굼시의 피부의 매끄러움을 향상시키기 위해서 함유된다.The cationic polymer as the component (B) is at least one selected from a dimethyldiallylammonium chloride polymer and a dimethyldiallylammonium chloride-acrylic acid copolymer, and is mainly used for skin elasticity after towel drying and skin smoothness during rinsing. are included to improve
상기 (B)성분 중의 염화디메틸디알릴암모늄-아크릴산 공중합체는 하기 일반식(B1)으로 나타내어진다.The dimethyldiallylammonium chloride-acrylic acid copolymer in the component (B) is represented by the following general formula (B1).
단, 상기 일반식(B1) 중, n, 및 m은 각 구조단위의 몰비(몰%)를 나타내고, n+m=100이며, 상기 m은 40몰% 이상이다.However, in Formula (B1), n and m represent the molar ratio (mol%) of each structural unit, n+m=100, and m is 40 mol% or more.
상기 (B)성분 중 염화디메틸디알릴암모늄-아크릴산 공중합체에 있어서의 염화디메틸디알릴암모늄으로부터 유래하는 구조단위의 몰비로서는 타올 드라이후의 피부의 탄력의 점에서, 65몰% 이상이 바람직하고, 96몰% 이상이 보다 바람직하다. Among the components (B), the molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer is preferably 65 mol% or more from the viewpoint of skin elasticity after towel drying, 96 mol% or more is more preferable.
상기 염화디메틸디알릴암모늄-아크릴산 공중합체는 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.The above dimethyldiallylammonium chloride-acrylic acid copolymer may be used alone or in combination of two or more.
상기 (B)성분 중 염화디메틸디알릴암모늄-아크릴산 공중합체에 있어서의 구조단위의 몰비는 핵자기공명(NMR)에 의해 하기 측정 조건으로 측정함으로써 결정할 수 있다.Among the components (B), the molar ratio of structural units in the dimethyldiallylammonium chloride-acrylic acid copolymer can be determined by measuring by nuclear magnetic resonance (NMR) under the following measurement conditions.
[측정 조건][Measuring conditions]
용매:중수(D2O)Solvent: heavy water (D 2 O)
측정기:JNM-LA300(300MHz, 니폰 덴시 가부시키가이샤제)Measuring device: JNM-LA300 (300 MHz, manufactured by Nippon Electronics Co., Ltd.)
상기 (B)성분의 양이온성 폴리머의 중량 평균 분자량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 10,000∼1,000,000이 바람직하고, 15,000∼450,000이 보다 바람직하다. The weight average molecular weight of the cationic polymer of the component (B) is not particularly limited and can be appropriately selected according to the purpose, but is preferably 10,000 to 1,000,000, and more preferably 15,000 to 450,000.
상기 (B)성분의 양이온성 폴리머의 중량 평균 분자량은 예를 들면, SEC-MALLS-RI 시스템(측정 조건: 컬럼 :토소 가부시키가이샤제 TSKgel α시리즈α-M 컬럼 30cm, 용매:질산 나트륨 0.3M 수용액)으로 측정할 수 있다.The weight average molecular weight of the cationic polymer of the component (B) is measured using, for example, the SEC-MALLS-RI system (measurement conditions: column: Tosoh Corporation TSKgel α series α-M column 30 cm, solvent: sodium nitrate 0.3 M aqueous solution).
상기 (B)성분의 양이온성 폴리머의 고형분 30질량%∼44질량%의 용액의 25℃에서의 점도는 10mPa·s∼15,000mPa·s가 바람직하고, 20mPa·s∼12,000mPa·s가 보다 바람직하다.The viscosity at 25°C of a solution containing 30% by mass to 44% by mass of the solid content of the cationic polymer of the component (B) is preferably 10 mPa s to 15,000 mPa s, more preferably 20 mPa s to 12,000 mPa s. do.
상기 점도는 예를 들면, 브룩필드 점도계 LVF(브룩필드사제)를 사용해서 측정할 수 있다.The said viscosity can be measured using, for example, a Brookfield viscometer LVF (manufactured by Brookfield Corporation).
상기 (B)성분의 양이온성 폴리머는 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다. 상기 (B)성분의 양이온성 폴리머의 시판품으로서는 예를 들면, 상품명으로 이하의 것 등을 들 수 있다.An appropriately synthesized cationic polymer of the component (B) may be used, or a commercially available product may be used. As a commercial item of the cationic polymer of the said (B) component, the following etc. are mentioned as a brand name, for example.
머코트(MERQUAT) 100(성분명:염화디메틸디알릴암모늄 중합체, 니폰 루브리졸 가부시키가이샤제, 고형분 39질량%∼44질량%의 25℃에서의 점도:8,000mPa·s∼12,000mPa·s, 중량 평균 분자량:150,000).MERQUAT 100 (ingredient name: dimethyldiallylammonium chloride polymer, manufactured by Nippon Lubrizol Co., Ltd., solid content of 39 mass% to 44 mass%, viscosity at 25 ° C.: 8,000 mPa s to 12,000 mPa s, weight average molecular weight: 150,000).
상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 3의 로터를 사용하고, 6회전/분간의 조건에 있어서 측정할 수 있다.The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 3, it can measure on the condition of 6 revolutions/minute.
머코트 106(성분명:염화디메틸디알릴암모늄 중합체, 니폰 루브리졸 가부시키가이샤제, 고형분 30질량%∼36질량%의 25℃에서의 점도:20mPa·s∼65mPa·s, 중량 평균 분자량 15,000).Mercoat 106 (ingredient name: dimethyldiallylammonium chloride polymer, manufactured by Nippon Lubrizol Co., Ltd., solid content of 30% by mass to 36% by mass, viscosity at 25°C: 20mPa s to 65mPa s, weight average molecular weight 15,000) .
상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 1의 로터를 사용하고, 60회전/분간의 조건에 있어서 측정할 수 있다.The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. 1 can be used and the measurement can be made under the condition of 60 revolutions/minute.
머코트 280(성분명:염화디메틸디알릴암모늄-아크릴산 공중합체, 니폰 루브리졸 가부시키가이샤제, 고형분 39질량%∼43질량%의 25℃에서의 점도:3,000mPa·s∼6,000mPa·s, 중량 평균 분자량 450,000, 상기 일반식(1)에 있어서의 n:m=35:65(몰비), 염화디메틸디알릴암모늄으로부터 유래하는 구조단위의 몰비가 65몰%).Mercoat 280 (ingredient name: dimethyldiallylammonium chloride-acrylic acid copolymer, manufactured by Nippon Lubrizol Co., Ltd., solid content of 39 mass% to 43 mass%, viscosity at 25 ° C.: 3,000 mPa s to 6,000 mPa s, Weight average molecular weight 450,000, n:m = 35:65 (molar ratio) in the above general formula (1), molar ratio of structural units derived from dimethyldiallylammonium chloride is 65 mol%).
상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 4의 로터를 사용하고, 60회전/분간의 조건에 있어서 측정할 수 있다.The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 4, it can measure on the condition of 60 revolutions/minute.
머코트 295(성분명:염화디메틸디알릴암모늄-아크릴산 공중합체, 니폰 루브리졸 가부시키가이샤제, 고형분 35질량%∼40질량%의 25℃에서의 점도:3,500mPa·s∼9,000mPa·s, 중량 평균 분자량 190,000, 상기 일반식(1)에 있어서의 n:m=5:95(몰비), 염화디메틸디알릴암모늄으로부터 유래하는 구조단위의 몰비가 95몰%).Mercourt 295 (ingredient name: dimethyldiallylammonium chloride-acrylic acid copolymer, manufactured by Nippon Lubrizol Co., Ltd., solid content of 35 mass% to 40 mass%, viscosity at 25° C.: 3,500 mPa s to 9,000 mPa s, Weight average molecular weight 190,000, n:m = 5:95 (molar ratio) in the above general formula (1), molar ratio of structural units derived from dimethyldiallylammonium chloride is 95 mol%).
상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 4의 로터를 사용하고, 30회전/분간의 조건에 있어서 측정할 수 있다.The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 4, it can measure on the condition of 30 revolutions/minute.
이들 중에서도, 상기 (B)성분의 양이온성 폴리머로서는 타올 드라이후의 피부의 탄력의 점에서, 머코트 100, 머코트 280, 머코트 295가 바람직하다.Among these, as the cationic polymer of the component (B), in view of skin elasticity after towel drying, Mercury 100, Mercury 280, and Mercury 295 are preferable.
상기 (B)성분의 양이온성 폴리머의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 거품 유지, 타올 드라이후의 피부의 탄력 및 헹굼시의 피부의 매끄러움의 점에서, 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼1질량%가 바람직하고, 0.2질량%∼0.8질량%가 보다 바람직하다. 상기 (B)성분의 함유량이 0.1질량% 이상이면, 타올 드라이후의 피부의 탄력이 양호하며, 1질량% 이하이면, 타올 드라이후의 피부의 당김감을 느끼지 않고 양호하다.The content of the cationic polymer of the component (B) is not particularly limited and can be appropriately selected according to the purpose, but in terms of foam retention, skin elasticity after towel drying, and skin smoothness during rinsing, a liquid skin cleanser composition 0.1 mass % - 1 mass % are preferable with respect to the whole quantity, and 0.2 mass % - 0.8 mass % are more preferable. When the content of the component (B) is 0.1% by mass or more, the elasticity of the skin after towel-drying is good, and when it is 1% by mass or less, the skin does not feel tight after towel-drying.
<(C)폴리에틸렌글리콜><(C) polyethylene glycol>
상기 (C)성분으로서의 폴리에틸렌글리콜은 평균 분자량이 190∼630인 폴리에틸렌글리콜이며, 주로, 타올 드라이후의 피부의 탄력 및 저온 안정성을 향상시키기 위해서 함유된다.Polyethylene glycol as the component (C) is polyethylene glycol having an average molecular weight of 190 to 630, and is mainly contained to improve skin elasticity and low-temperature stability after towel drying.
상기 (C)성분의 평균 분자량이 630을 초과하면, 타올 드라이후의 피부의 탄력이 저하된다. 또한, 평균 분자량이 190 미만인 폴리에틸렌글리콜의 시판품은 존재하지 않는다.When the average molecular weight of the component (C) exceeds 630, elasticity of the skin after towel drying decreases. In addition, commercially available products of polyethylene glycol having an average molecular weight of less than 190 do not exist.
상기 평균 분자량은 의약 부외품 원료규격 2006에 기재된 평균 분자량 시험에 의해 측정할 수 있다.The average molecular weight can be measured by the average molecular weight test described in the Quasi-drug Raw Materials Standard 2006.
상기 (C)성분의 폴리에틸렌글리콜로서는 예를 들면, 폴리에틸렌글리콜 200(평균 분자량 190∼210), 폴리에틸렌글리콜 300(평균 분자량 280∼320), 폴리에틸렌글리콜 400(평균 분자량 380∼420), 폴리에틸렌글리콜 600(평균 분자량 570∼630) 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다. 이들 중에서도, 상기 (C)성분으로서는 타올 드라이후의 피부의 탄력 및 저온 안정성의 점에서, 폴리에틸렌글리콜 400(평균 분자량 380∼420)이 바람직하다. Examples of the polyethylene glycol of the component (C) include polyethylene glycol 200 (average molecular weight 190 to 210), polyethylene glycol 300 (average molecular weight 280 to 320), polyethylene glycol 400 (average molecular weight 380 to 420), polyethylene glycol 600 ( Average molecular weight 570-630) etc. are mentioned. These may be used individually by 1 type, and may use 2 or more types together. Among these, as the component (C), polyethylene glycol 400 (average molecular weight: 380 to 420) is preferable from the viewpoint of skin elasticity after towel drying and low-temperature stability.
또한, 상품에 따라서는 예를 들면, 폴리에틸렌글리콜 200은 폴리에틸렌글리콜 # 200 등과 같이, 폴리에틸렌글리콜과 수치 사이에 #이 붙는 경우가 있다. In addition, depending on the product, for example, polyethylene glycol 200 may have # attached between the polyethylene glycol and the numerical value, such as polyethylene glycol # 200.
상기 (C)성분의 폴리에틸렌글리콜의 함유량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 타올 드라이후의 피부의 탄력 및 저온 안정성의 점에서, 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼1.0질량%가 바람직하고, 0.2질량%∼0.8질량%가 보다 바람직하다. 상기 (C)성분의 함유량이 0.1질량% 이상이면, 타올 드라이후의 피부의 탄력 및 저온 안정성이 양호하며, 1.0질량% 이하이면, 저온 안정성이 양호하다.The content of polyethylene glycol in the component (C) is not particularly limited and can be appropriately selected according to the purpose, but from the viewpoint of elasticity of the skin after towel drying and low-temperature stability, it is 0.1% by mass to 1.0 with respect to the total amount of the liquid skin cleanser composition. Mass % is preferable, and 0.2 mass % - 0.8 mass % are more preferable. When the content of the component (C) is 0.1% by mass or more, the elasticity and low-temperature stability of the skin after towel drying are good, and when the content is 1.0% by mass or less, the low-temperature stability is good.
<질량비[(A)/(C)]><Mass Ratio [(A)/(C)]>
상기 (C)성분의 함유량에 대한 상기 (A)성분의 함유량의 질량비[(A)/(C)]로서는 거품 유지, 타올 드라이후의 피부의 탄력, 및 저온 안정성의 점에서, 15∼100이지만, 20∼40이 바람직하다. 상기 질량비[(A)/(C)]가 15 미만이면, 거품 유지가 불충분하게 되고, 100을 초과하면, 타올 드라이후의 피부의 탄력 및 저온 안정성이 불충분하게 된다.The mass ratio [(A)/(C)] of the content of the component (A) to the content of the component (C) is 15 to 100 in terms of foam retention, skin elasticity after towel drying, and low-temperature stability. , 20 to 40 are preferable. If the mass ratio [(A)/(C)] is less than 15, foam retention becomes insufficient, and if it exceeds 100, skin elasticity and low-temperature stability after towel drying become insufficient.
<(D)하기 일반식(1)으로 나타내어지는 공중합체><(D) Copolymer represented by the following general formula (1)>
상기 (D)성분의 공중합체는 헹굼시의 피부의 매끄러움을 향상시키기 위해서 함유되는 것이 바람직하다.The copolymer of the above component (D) is preferably contained in order to improve skin smoothness during rinsing.
상기 (D)성분의 공중합체는 하기 일반식(1)으로 나타내어지는 공중합체이다.The copolymer of the said component (D) is a copolymer represented by the following general formula (1).
단, 상기 일반식(1) 중, n, m, 및 z는 각 구조단위의 몰비(몰%)를 나타내고, n+m+z=100이다.However, in the above general formula (1), n, m, and z represent the molar ratio (mol%) of each structural unit, and n+m+z=100.
상기 n은 0∼34가 바람직하고, 상기 m은 24∼31이 바람직하고, 상기 z는 35∼76이 바람직하다.The n is preferably 0 to 34, the m is preferably 24 to 31, and the z is preferably 35 to 76.
이들 중에서도, 헹굼시의 피부의 매끄러움의 점에서, 상기 일반식(1)에 있어서의 n:m:z=0:24:76이 바람직하다.Among these, n:m:z=0:24:76 in the said general formula (1) is preferable from the point of skin smoothness at the time of rinsing.
상기 (D)성분의 공중합체에 있어서의 각 구조단위의 몰비는 핵자기공명(NMR)에 의해 하기 측정 조건으로 측정함으로써 결정할 수 있다.The molar ratio of each structural unit in the copolymer of the component (D) can be determined by measuring by nuclear magnetic resonance (NMR) under the following measurement conditions.
[측정 조건][Measuring conditions]
용매:중수(D2O)Solvent: heavy water (D 2 O)
측정기:JNM-LA300(300MHz, 니폰 덴시 가부시키가이샤제)Measuring device: JNM-LA300 (300 MHz, manufactured by Nippon Electronics Co., Ltd.)
상기 (D)성분의 공중합체의 중량 평균 분자량으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 100,000∼3,000,000이 바람직하고, 100,000∼1,600,000이 보다 바람직하다. 상기 (D)성분의 공중합체의 중량 평균 분자량은 예를 들면, SEC-MALLS-RI 시스템(측정 조건: 컬럼 :토소 가부시키가이샤제 TSKgel α시리즈α-M 컬럼 30cm, 용매:질산 나트륨 0.3M 수용액)으로 측정할 수 있다.The weight average molecular weight of the copolymer of component (D) is not particularly limited and can be appropriately selected according to the purpose, but is preferably 100,000 to 3,000,000, more preferably 100,000 to 1,600,000. The weight average molecular weight of the copolymer of the component (D) is, for example, SEC-MALLS-RI system (measurement conditions: column: Tosoh Corporation TSKgel α series α-M column 30 cm, solvent: sodium nitrate 0.3M aqueous solution ) can be measured.
상기 (D)성분의 공중합체에 있어서의 고형분 8질량%∼45질량%의 상기 공중합체용액의 25℃에서의 점도로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 1,500mPa·s∼16,000mPa·s가 바람직하다. The viscosity at 25°C of the copolymer solution having a solid content of 8% to 45% by mass in the copolymer of component (D) is not particularly limited and can be appropriately selected according to the purpose, but is 1,500 mPa·s to 16,000 mPa·s is preferred.
상기 점도는 예를 들면, 브룩필드 점도계 LVF(브룩필드사제)를 사용해서 측정할 수 있다.The said viscosity can be measured using, for example, a Brookfield viscometer LVF (manufactured by Brookfield Corporation).
상기 (D)성분의 공중합체로서는 적당히 합성한 것을 사용해도 좋고, 시판품을 사용해도 좋다. 상기 시판품으로서는 이하의 것 등을 들 수 있다.As a copolymer of the said (D) component, what was synthesize|combined suitably may be used, and a commercial item may be used. As said commercial item, the following etc. are mentioned.
머코트 550PR(성분명:염화디메틸알릴암모늄-아크릴아미드 공중합체, 루브리졸사제, 고형분 8.8질량%∼9.8질량%의 25℃에서의 점도:7,500mPa·s∼15,000mPa·s, 중량 평균 분자량:1,600,000, 상기 일반식(1)에 있어서의 n:m:z=0:30:70). 상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 4의 로터를 사용하고, 10회전/분간의 조건으로 측정할 수 있다. Mercoat 550PR (ingredient name: dimethylallylammonium chloride-acrylamide copolymer, manufactured by Lubrizol Co., Ltd., solid content of 8.8% to 9.8% by mass, viscosity at 25°C: 7,500 mPa s to 15,000 mPa s, weight average molecular weight: 1,600,000, n:m:z = 0:30:70 in the above general formula (1)). The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 4, it can measure under the condition of 10 revolutions/minute.
머코트 740(성분명:염화디메틸알릴암모늄-아크릴아미드 공중합체, 루브리졸사제, 고형분 41질량%∼45질량%의 25℃에서의 점도:2,000mPa·s∼12,000mPa·s, 중량 평균 분자량:120,000, 상기 일반식(1)에 있어서의 n:m:z=0:24:76). 상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 4의 로터를 사용하고, 10회전/분간의 조건으로 측정할 수 있다.Mercot 740 (ingredient name: dimethylallylammonium chloride-acrylamide copolymer, manufactured by Lubrizol Co., Ltd., solid content of 41% to 45% by mass, viscosity at 25° C.: 2,000 mPa s to 12,000 mPa s, weight average molecular weight: 120,000, n:m:z = 0:24:76 in the above general formula (1)). The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 4, it can measure under the condition of 10 revolutions/minute.
머코트 3330PR(성분명:아크릴산-염화디메틸디알릴암모늄-아크릴아미드 공중합체, 루브리졸사제, 고형분 10.2질량%∼11.5질량%의 25℃에서의 점도:1,000mPa·s∼6,000mPa·s, 중량 평균 분자량:1,500,000, 상기 일반식(1)에 있어서의 n:m:z=34:31:35). 상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 4의 로터를 사용하고, 30회전/분간의 조건으로 측정할 수 있다.Mercoat 3330PR (ingredient name: acrylic acid-dimethyldiallylammonium chloride-acrylamide copolymer, manufactured by Lubrizol Co., Ltd., solid content of 10.2% by mass to 11.5% by mass, viscosity at 25°C: 1,000 mPa s to 6,000 mPa s, weight Average molecular weight: 1,500,000, n:m:z = 34:31:35 in the above general formula (1)). The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 4, it can measure under the condition of 30 revolutions/minute.
머코트 3331PR(성분명:아크릴산-염화디메틸디알릴암모늄-아크릴아미드 공중합체, 루브리졸사제, 고형분 9.7질량%∼10.7질량%의 25℃에서의 점도:2,000mPa·s∼12,000mPa·s, 중량 평균 분자량:1,600,000, 상기 일반식(1)에 있어서의 n:m:z=22.5:26.5:51). 상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 5의 로터를 사용하고, 30회전/분간의 조건으로 측정할 수 있다.Mercoat 3331PR (ingredient name: acrylic acid-dimethyldiallylammonium chloride-acrylamide copolymer, manufactured by Lubrizol Co., Ltd., solid content of 9.7% to 10.7% by mass, viscosity at 25°C: 2,000 mPa s to 12,000 mPa s, weight Average molecular weight: 1,600,000, n:m:z = 22.5:26.5:51 in the above general formula (1)). The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 5, it can measure under the condition of 30 revolutions/minute.
머코트 3940(성분명:아크릴산-염화디메틸디알릴암모늄-아크릴아미드 공중합체, 루브리졸사제, 고형분 41질량%∼45질량%의 25℃에서의 점도:1,500mPa·s∼4,500mPa·s, 중량 평균 분자량:150,000, 상기 일반식(1)에 있어서의 n:m:z=31:29:40). 상기 점도는 브룩필드 점도계 LVF(브룩필드사제)를 사용하고, 25℃에서 스핀들 No. 3의 로터를 사용하고, 10회전/분간의 조건으로 측정할 수 있다.Mercoat 3940 (ingredient name: acrylic acid-dimethyldiallylammonium chloride-acrylamide copolymer, manufactured by Lubrizol Co., Ltd., solid content: 41% by mass to 45% by mass, viscosity at 25°C: 1,500 mPa s to 4,500 mPa s, weight Average molecular weight: 150,000, n:m:z = 31:29:40 in the above general formula (1)). The viscosity was measured using a Brookfield viscometer LVF (manufactured by Brookfield) at 25 ° C. Spindle No. Using the rotor of 3, it can measure under the condition of 10 revolutions/minute.
이들 중에서도, 상기 (D)성분의 공중합체로서는 헹굼시의 피부의 매끄러움의 점에서, 머코트 740이 바람직하다.Among these, as a copolymer of the said (D) component, Mercoat 740 is preferable from the point of skin smoothness at the time of a rinse.
상기 (D)성분의 공중합체의 함유량으로서는 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 당김감의 점에서, 상기 액체 피부 세정제 조성물 전량에 대해서 0.01질량%∼0.5질량%가 바람직하고, 0.05질량%∼0.3질량%가 보다 바람직하다. 상기 (D)성분의 함유량이 0.01질량% 이상이면, 헹굼시의 피부의 매끄러움이 양호하며, 0.5질량% 이하이면, 타올 드라이후의 피부의 당김감이 양호하다.As content of the copolymer of the said (D) component, 0.01 mass % - 0.5 mass % is preferable with respect to the said liquid skin cleanser composition whole amount from the point of the smoothness of skin at the time of rinsing, and the tightening feeling of skin after towel drying, and it is 0.05 Mass % - 0.3 mass % are more preferable. When the content of the component (D) is 0.01% by mass or more, the smoothness of the skin during rinsing is good, and when it is 0.5% by mass or less, the skin feels good after towel drying.
<그 밖의 성분><Other ingredients>
상기 액체 피부 세정제 조성물에는 상기 (A)성분, 상기 (B)성분, 상기 (C)성분, 및 상기 (D)의 각 성분 이외에도, 본 발명의 효과를 손상하지 않는 범위에서 필요에 따라서, 그 밖의 성분을 배합할 수 있다.In the liquid skin cleanser composition, in addition to the components of (A), (B), (C), and (D), as necessary within a range not impairing the effects of the present invention, other Ingredients can be combined.
상기 그 밖의 성분으로서는 예를 들면, 상기 (A)성분 이외의 계면활성제, 상기 (B)성분 및 상기 (D)성분 이외의 수용성 고분자, 유분, 실리콘류, 알콜류, 라놀린 유도체, 단백 유도체, 약제(예를 들면, 비타민류 등), 보습제, 살균제, 방부제, pH 조정제, 산화 방지제, 금속봉쇄제, 자외선흡수·산란제, 동식물 추출물 또는 그 유도체, 킬레이트제, 자외선흡수·산란제, 아미노산류, 색소, 향료, 안료, 무기분체, 점토광물, 수불용성 고분자 화합물 분체 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the other components include surfactants other than component (A), water-soluble polymers, oils, silicones, alcohols, lanolin derivatives, protein derivatives, drugs other than component (B) and component (D) ( For example, vitamins, etc.), moisturizers, bactericides, preservatives, pH adjusters, antioxidants, metal sequestering agents, UV absorbers/scattering agents, animal and plant extracts or their derivatives, chelating agents, UV absorbers/scattering agents, amino acids, pigments , perfumes, pigments, inorganic powders, clay minerals, water-insoluble polymer compound powders, and the like. These may be used individually by 1 type, and may use 2 or more types together.
상기 유분으로서는 예를 들면, 피마자유, 올리브유, 카카오유, 경화 팜유, 동백유, 야자유, 목납, 호호바유, 포도씨유, 아보카도유 등의 식물 유지류 및 이들의 에스테르 화합물; 밍크유, 난황유 등의 동물 유지류; 밀납, 경납, 라놀린, 수첨 라놀린, 카르나우바납, 칸데릴라납 등의 납류; 유동 파라핀, 스쿠알란, 마이크로크리스탈린 왁스, 세레신 왁스, 파라핀 왁스, 바셀린 등의 탄화수소류; 올레산, 이소스테아르산, 베헨산 등의 천연 및 합성 지방산류; 글리세롤트리-2-에틸헥산산 에스테르, 2-에틸헥실스테아레이트, 스테아르산 부틸, 미리스틴산 이소프로필, 팔미트산 이소프로필, 미리스틴산 옥틸도데실, 올레산 옥틸도데실, 콜레스테롤올레이트 등의 에스테르류 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the oil component include plant oils and oils such as castor oil, olive oil, cacao oil, hardened palm oil, camellia oil, coconut oil, wood wax, jojoba oil, grapeseed oil, and avocado oil, and ester compounds thereof; animal fats and oils such as mink oil and egg yolk oil; waxes such as beeswax, spermaceti, lanolin, hydrogenated lanolin, carnauba wax, and candelilla wax; hydrocarbons such as liquid paraffin, squalane, microcrystalline wax, ceresin wax, paraffin wax, and petrolatum; natural and synthetic fatty acids such as oleic acid, isostearic acid, and behenic acid; Glycerol tri-2-ethylhexanoic acid ester, 2-ethylhexylstearate, butyl stearate, isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, octyldodecyl oleate, cholesterol oleate, etc. Ester etc. are mentioned. These may be used individually by 1 type, and may use 2 or more types together.
상기 유분의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼3질량%가 바람직하다.The content of the oil component is not particularly limited as long as the effect of the present invention is not impaired, and can be appropriately selected according to the purpose, but is preferably 0.1% by mass to 3% by mass based on the total amount of the liquid skin cleanser composition.
상기 알콜류로서는 예를 들면, 저급 또는 고급 알콜 등을 들 수 있고, 그 구체예로서는 세틸알콜, 올레일알콜, 스테아릴알콜, 헥실데카놀, 옥틸도데카놀, 라우릴알콜 등의 천연 및 합성 고급 알콜류 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the alcohols include lower and higher alcohols, and specific examples thereof include natural and synthetic higher alcohols such as cetyl alcohol, oleyl alcohol, stearyl alcohol, hexyldecanol, octyldodecanol, and lauryl alcohol. etc. can be mentioned. These may be used individually by 1 type, and may use 2 or more types together.
상기 알콜류의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼3질량%가 바람직하다. The content of the alcohols is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately selected according to the purpose, but is preferably 0.1% by mass to 3% by mass based on the total amount of the liquid skin cleanser composition.
상기 보습제로서는 예를 들면, 이소프렌글리콜, 1,2-펜탄디올, 디에틸렌글리콜, 디에틸렌글리콜모노알킬에테르, 폴리프로필렌글리콜, 폴리프로필렌글리콜, 경화 피마자유(30E.O.), 디글리세린, 트리글리세린, 폴리글리세린 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the moisturizing agent include isoprene glycol, 1,2-pentanediol, diethylene glycol, diethylene glycol monoalkyl ether, polypropylene glycol, polypropylene glycol, hydrogenated castor oil (30E.O.), diglycerin, and triglyceride. Glycerin, polyglycerol, etc. are mentioned. These may be used individually by 1 type, and may use 2 or more types together.
상기 알콜류의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼10질량%가 바람직하다.The content of the alcohols is not particularly limited as long as the effect of the present invention is not impaired, and can be appropriately selected according to the purpose, but is preferably 0.1% by mass to 10% by mass based on the total amount of the liquid skin cleanser composition.
상기 방부제로서는 예를 들면, 벤조산염, 소르빈산염, 데히드로 아세트산염, 파라옥시 벤조산 에스테르, 2,4,4'-트리클로로-2'-히드록시디페닐에테르, 3,4,4'-트리클로로카르바니리드, 염화벤잘코늄, 히노키티올, 레조르신, 메틸클로로이소티아졸리논·메틸이소티아졸리논액(상품명:케이슨 CG, 롬앤드하스 재팬사제), 살리실산, 펜탄디올, 페녹시에탄올, 에탄올 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the preservative include benzoate, sorbate, dehydroacetate, paraoxybenzoic acid ester, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichloro Locarbaniride, benzalkonium chloride, hinokitiol, resorcin, methylchloroisothiazolinone/methylisothiazolinone solution (trade name: Kayson CG, manufactured by Rohm and Haas Japan), salicylic acid, pentanediol, phenoxyethanol, ethanol etc. can be mentioned. These may be used individually by 1 type, and may use 2 or more types together.
상기 방부제의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼1질량%가 바람직하다.The content of the preservative is not particularly limited as long as the effect of the present invention is not impaired, and can be appropriately selected according to the purpose, but is preferably 0.1% by mass to 1% by mass based on the total amount of the liquid skin cleanser composition.
상기 산화 방지제로서는 예를 들면, 디부틸히드록시톨루엔, 부틸히드록시아니솔, 아스코르브산 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, and ascorbic acid. These may be used individually by 1 type, and may use 2 or more types together.
상기 산화 방지제의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼1질량%가 바람직하다.The content of the antioxidant is not particularly limited as long as the effect of the present invention is not impaired, and may be appropriately selected according to the purpose, but is preferably 0.1% by mass to 1% by mass based on the total amount of the liquid skin cleanser composition.
상기 킬레이트제로서는 예를 들면, 에데트산 2나트륨, 에틸렌디아민 4아세트산염, 헥사메타 인산염, 글루콘산 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다. Examples of the chelating agent include disodium edetate, ethylenediamine tetraacetate, hexametaphosphate, and gluconic acid. These may be used individually by 1 type, and may use 2 or more types together.
상기 킬레이트제의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.1질량%∼1질량%가 바람직하다.The content of the chelating agent is not particularly limited as long as the effect of the present invention is not impaired, and can be appropriately selected according to the purpose, but is preferably 0.1% by mass to 1% by mass based on the total amount of the liquid skin cleanser composition.
상기 pH 조정제로서는 예를 들면, 수산화 나트륨, 수산화 칼륨, 시트르산, 염산, 숙신산, 트리에탄올아민, 암모니아수, 트리이소프로파놀아민, 인산, 글리콜산 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the pH adjuster include sodium hydroxide, potassium hydroxide, citric acid, hydrochloric acid, succinic acid, triethanolamine, aqueous ammonia, triisopropanolamine, phosphoric acid, glycolic acid and the like. These may be used individually by 1 type, and may use 2 or more types together.
상기 자외선흡수·산란제로서는 예를 들면, 2-히드록시-4-메톡시벤조페논, 옥틸디메틸파라아미노벤조에이트, 에틸헥실파라메톡시사이나메이트, 산화 티타늄, 카올린, 탤크 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the ultraviolet absorbing/scattering agent include 2-hydroxy-4-methoxybenzophenone, octyldimethylparaaminobenzoate, ethylhexylparamethoxycynamate, titanium oxide, kaolin, and talc. . These may be used individually by 1 type, and may use 2 or more types together.
상기 비타민류로서는 예를 들면, 비타민 A, 비타민 B군, 비타민 C, 비타민 D, 비타민 E, 비타민 F, 비타민 K, 비타민 P, 비타민 U, 카르니틴, 페룰라산, γ-오리자놀, α-리포산, 오로트산 및 그 유도체 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the above vitamins include vitamin A, vitamin B group, vitamin C, vitamin D, vitamin E, vitamin F, vitamin K, vitamin P, vitamin U, carnitine, ferulic acid, γ-oryzanol, α-lipoic acid, oh rotic acid and derivatives thereof; and the like. These may be used individually by 1 type, and may use 2 or more types together.
상기 비타민류의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.001질량%∼0.5질량%가 바람직하다.The content of the vitamins is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately selected according to the purpose, but is preferably 0.001% by mass to 0.5% by mass based on the total amount of the liquid skin cleanser composition.
상기 아미노산류로서는 예를 들면, 글리신, 알라닌, 발린, 류신, 이소류신, 페닐알라닌, 트립토판, 시스틴, 시스테인, 메티오닌, 프롤린, 히드록시프롤린, 아스파르트산, 글루탐산, 아르기닌, 히스티딘, 리신 및 그 유도체 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the amino acids include glycine, alanine, valine, leucine, isoleucine, phenylalanine, tryptophan, cystine, cysteine, methionine, proline, hydroxyproline, aspartic acid, glutamic acid, arginine, histidine, lysine and derivatives thereof. can These may be used individually by 1 type, and may use 2 or more types together.
상기 아미노산류의 함유량으로서는 본 발명의 효과를 손상하지 않는 한, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 상기 액체 피부 세정제 조성물 전량에 대해서 0.001질량%∼0.5질량%가 바람직하다.The content of the amino acids is not particularly limited as long as the effect of the present invention is not impaired, and can be appropriately selected according to the purpose, but is preferably 0.001% by mass to 0.5% by mass based on the total amount of the liquid skin cleanser composition.
상기 수불용성 고분자 화합물 분체로서는 예를 들면, 나일론, 폴리에틸렌 등을 들 수 있다. 이들은 1종 단독으로 사용해도 좋고, 2종 이상을 병용해도 좋다.Examples of the water-insoluble polymer compound powder include nylon and polyethylene. These may be used individually by 1 type, and may use 2 or more types together.
-pH--pH-
상기 액체 피부 세정제 조성물의 25℃에 있어서의 pH로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 9.5∼11.0이 바람직하고, 9.8∼10.6이 보다 바람직하다.The pH of the liquid skin cleanser composition at 25°C is not particularly limited and can be appropriately selected according to the purpose, but is preferably 9.5 to 11.0 and more preferably 9.8 to 10.6.
상기 pH는 예를 들면, 유리 전극색 수소 이온 농도 지시계 HM-30R(도아 디케이케이사제 전극 타입 GST-5721)을 사용해서 측정할 수 있다.The pH can be measured using, for example, a glass electrode color hydrogen ion concentration indicator HM-30R (electrode type GST-5721 manufactured by Toa DKK Co., Ltd.).
-점도--viscosity-
상기 액체 피부 세정제 조성물의 25℃에 있어서의 점도로서는 특별히 제한은 없고, 사용하는 용기 등에 따라 적당히 선택할 수 있지만, 4mPa·s∼40mPa·s가 바람직하고, 8mPa·s∼30mPa·s가 보다 바람직하다. The viscosity of the liquid skin cleanser composition at 25°C is not particularly limited and can be appropriately selected depending on the container to be used, but is preferably 4 mPa·s to 40 mPa·s, and more preferably 8 mPa·s to 30 mPa·s. .
예를 들면, 노즐부를 밀어 내리는 것에 의해 거품을 토출할 수 있는 펌프 포머 용기와, 305메시 및 200메시의 다공질막체를 각 1매 사용할 때에 있어서, 사용하는 온도조건 하에서 상기 액체 피부 세정제 조성물의 점도는 30mPa·s 이하가 바람직하고, 25mPa·s 이하가 보다 바람직하다. For example, when using a pump foamer container capable of discharging bubbles by pushing down the nozzle part and a porous membrane body of 305 mesh and 200 mesh respectively, the viscosity of the liquid skin cleanser composition under the temperature conditions used is 30 mPa·s or less is preferable, and 25 mPa·s or less is more preferable.
상기 점도는 예를 들면, BM형 점도계(가부시키가이샤 토쿄 케이키제)를 사용하고, 시료온도 25℃에서, 회전수 60rpm, No. 1의 로터로 1분간후의 점도를 측정함으로써 측정할 수 있다.The viscosity was measured using, for example, a BM-type viscometer (manufactured by Tokyo Keiki Co., Ltd.) at a sample temperature of 25°C, a rotation speed of 60 rpm, and No. It can be measured by measuring the viscosity after 1 minute with the rotor of No. 1.
-용기--courage-
상기 액체 피부 세정제 조성물은 포머 용기에 충전되어서 이루어지고 거품상으로 토출되는 타입의 것이다. The liquid skin cleanser composition is of a type that is filled in a foamer container and discharged in the form of bubbles.
상기 포머 용기로서는 특별히 제한은 없고, 공지의 포머 용기 중에서 적당히 선택할 수 있고, 예를 들면, 논가스형의 거품토출용기, 분사제와 내압용기를 사용한 에어로졸 용기 등을 들 수 있다. 이들 중에서도, 논가스형의 거품토출용기가 바람직하다.The foamer container is not particularly limited and can be appropriately selected from known foamer containers, and examples thereof include a non-gas type bubble discharge container, an aerosol container using a propellant and a pressure-resistant container, and the like. Among these, a non-gas type bubble discharge container is preferable.
상기 논가스형의 거품토출용기로서는 상기 액체 피부 세정제 조성물을 공기와 혼합해서 발포 상태로 토출할 수 있는 것이면, 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 보틀 몸통부를 손으로 압착함으로써 거품을 토출할 수 있는 스퀴즈 포머 용기, 노즐부를 밀어 내리는 것에 의해 거품을 토출할 수 있는 펌프 포머 용기 등을 들 수 있다. 이러한 포머 용기는 다이와 세이칸 가부시키가이샤제, 가부시키가이샤 요시노 고교쇼제 등의 것을 사용할 수 있다. 보다 구체적으로는 포머 용기로서는 일본 특허공개 평 7-315463호 공보, 일본 특허공개 평 8-230961호 공보, 일본 특허공개 2005-193972호 공보 등에 기재된 포머 용기 등을 사용할 수 있다.The non-gas type bubble discharge container is not particularly limited as long as the liquid skin cleanser composition can be mixed with air and discharged in a foamed state, and can be appropriately selected according to the purpose. A squeeze former container capable of discharging bubbles by squeezing, a pump former container capable of discharging bubbles by pushing down a nozzle portion, and the like are exemplified. As such a former container, those manufactured by Daiwa Seikan Co., Ltd., manufactured by Yoshino Kogyosho Co., Ltd., and the like can be used. More specifically, as the former container, a former container described in Japanese Unexamined Patent Publication No. 7-315463, Japanese Unexamined Patent Publication No. Hei 8-230961, Japanese Unexamined Patent Publication No. 2005-193972, etc. can be used.
상기 논가스형의 거품토출용기는 거품형성 부재를 갖고, 구체적으로는 거품을 형성하기 위한 다공질막체(재질은 나일론, 폴리에스테르, 폴리올레핀 등의 플라스틱 재료가 바람직하다)를 갖고, 상기 액체 피부 세정제 조성물이 상기 다공질막체를 통과함으로써 거품이 형성되는 것이다.The non-gas type bubble discharge container has a bubble-forming member, specifically, has a porous film body for forming bubbles (preferably a plastic material such as nylon, polyester, or polyolefin), and the liquid skin cleanser composition described above. Bubbles are formed by passing through this porous membrane body.
상기 다공질막체의 메시로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 100메시 이상이 바람직하고, 100메시∼400메시가 보다 바람직하고, 200메시∼305메시가 특히 바람직하다. The mesh of the porous membrane body is not particularly limited and can be appropriately selected according to the purpose, but preferably 100 mesh or more, more preferably 100 mesh to 400 mesh, and particularly preferably 200 mesh to 305 mesh.
또한, 상기 다공질막체의 매수로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 거품성능을 향상시키는 관점에서, 2매∼4매가 바람직하다.In addition, the number of the porous membrane body is not particularly limited and can be appropriately selected according to the purpose, but from the viewpoint of improving the foaming performance, 2 to 4 sheets are preferable.
-제조 방법--Manufacturing method-
상기 액체 피부 세정제 조성물의 제조 방법으로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 상기 (A)성분, 상기 (B)성분, 및 상기 (C)성분, 또한 필요에 따라서, 상기 (D)성분, 상기 그 밖의 성분, 및 정제수(액체 피부 세정제 조성물 전체가 100질량%가 되도록 잔량으로서 배합)를 혼합해서 얻을 수 있다.The method for producing the liquid skin cleanser composition is not particularly limited, and may be appropriately selected according to the purpose. For example, the (A) component, the (B) component, and the (C) component, as necessary, It can obtain by mixing the said (D) component, the said other component, and purified water (blending as a residual amount so that the whole liquid skin cleanser composition may be 100 mass %).
구체적으로는 70℃∼80℃로 가온한 정제수에 상기 (A)성분을 용해하고, 40℃ 이하로 냉각하고나서, 상기 (B)성분, 상기 (C)성분, 및, 필요에 따라 상기 (D)성분 및 상기 그 밖의 성분을 첨가해서 제조할 수 있다.Specifically, after dissolving the component (A) in purified water heated to 70 ° C. to 80 ° C., cooling to 40 ° C. or lower, the component (B), the component (C), and, if necessary, the component (D ) component and the above other components can be added and manufactured.
상기 액체 피부 세정제 조성물은 장치를 사용해서 조제해도 좋다. 상기 장치로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 전단력이 있고, 전체를 혼합할 수 있는 교반 날개를 구비한 교반 장치 등을 들 수 있다.You may prepare the said liquid skin cleanser composition using an apparatus. The device is not particularly limited and can be appropriately selected according to the purpose, and examples thereof include a stirring device having a shear force and having a stirring blade capable of mixing the whole.
상기 교반 날개로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 프로펠러, 터빈, 디스퍼 등을 들 수 있다.There is no restriction|limiting in particular as said stirring blade, It can select suitably according to the purpose, For example, a propeller, a turbine, a disper, etc. are mentioned.
-용도--Usage-
상기 액체 피부 세정제 조성물의 사용 부위로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있고, 예를 들면, 전신, 얼굴, 손 등에 사용할 수 있다.The use site of the liquid skin cleanser composition is not particularly limited and can be appropriately selected according to the purpose, and can be used for the whole body, face, hands, etc., for example.
상기 액체 피부 세정제 조성물의 용도로서는 특별히 제한은 없고, 목적에 따라서 적당히 선택할 수 있지만, 거품 유지가 우수하고, 타올 드라이후의 피부에 당김감을 느끼지 않고, 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 탄력이 양호하며, 또한 저온 안정성이 우수하므로, 예를 들면, 바디 샴푸, 바디 소프, 세안폼, 핸드 소프, 거품 핸드 소프, 클렌징폼, 클렌저 등에 사용할 수 있고, 특히, 나일론 타올이나 면 타올 등의 세정 용구를 사용해서 거품을 내서 사용하는 바디 소프에 적합하게 사용할 수 있다.The use of the liquid skin cleanser composition is not particularly limited and can be appropriately selected according to the purpose, but it is excellent in foam retention, does not feel tightness on the skin after towel drying, smoothness of the skin during rinsing and skin after towel drying has good elasticity and excellent low-temperature stability, so it can be used, for example, in body shampoo, body soap, face wash foam, hand soap, foam hand soap, cleansing foam, cleanser, etc., in particular, nylon towels or cotton towels, etc. It can be used suitably for body soap that is used by lathering with the cleansing utensils of the above.
실시예Example
이하에, 실시예 및 비교예를 들어서 본 발명을 구체적으로 설명하지만, 본 발명은 이들의 실시예에 조금도 한정되는 것은 아니다.The present invention will be specifically described below by way of Examples and Comparative Examples, but the present invention is not limited to these Examples at all.
실시예 및 비교예에 기재된 각 성분의 함유량은 「질량%」로 나타내고, 전량은 100질량%이며, 모두 순분 환산한 값이다. 또한, (C)성분의 함유량(질량%)에 대한 (A)성분의 함유량(질량%)과의 질량비[(C)/(A)]는 소수점 이하 둘째자리를 사사 오입하고, 소수점 이하 첫째자리까지 구하고, 기재했다. (A)성분의 함유량에 대한 (a1)성분(팔미트산 칼륨)과 (a2)성분(스테아르산 칼륨)의 합계 함유량(질량%)의 질량비[((a1)+(a2))/(A)]는 소수점 이하 셋째자리를 사사 오입하고, 소수점 이하 둘째자리까지 구하고, 기재했다.The content of each component described in Examples and Comparative Examples is expressed as "% by mass", the total amount is 100% by mass, and all are values obtained in terms of pure parts. In addition, the mass ratio [(C)/(A)] of the content (mass%) of (A) component to the content (mass%) of (C) component [(C)/(A)] is rounded off to one decimal place, and up to, and recorded. Mass ratio of the total content (% by mass) of component (a1) (potassium palmitate) and component (a2) (potassium stearate) to the content of component (A) [((a1) + (a2)) / (A )] rounds off the third decimal place, obtains up to two decimal places, and writes.
(실시예 1∼11 및 19∼32, 및 비교예 1∼10)(Examples 1 to 11 and 19 to 32, and Comparative Examples 1 to 10)
하기 표 1∼표 5에 나타내는 조성, 및 함유량의 액체 피부 세정제 조성물을 이하의 방법에 준해서 조제했다.The liquid skin cleanser composition of the composition and content shown in following Table 1 - Table 5 was prepared according to the following method.
정제수를 70℃∼80℃로 가온하고, (A)성분의 음이온성 계면활성제를 용해하고, 40℃ 이하로 냉각하고나서, (B)성분의 양이온성 폴리머 또는 (B)성분의 비교 성분의 양이온화 셀룰로오스 및 (C)성분 또는 (C)성분의 비교 성분의 폴리에틸렌글리콜을 첨가했다. 상기 정제수는 최종적으로 얻어지는 액체 피부 세정제 조성물의 95질량%가 되는 양을 사용했다. 그 후, 소정의 pH(pH10.0)에 미치지 못하는 경우는 공통 성분인 수산화 칼륨을 첨가하고, 소정의 pH를 10.0으로 조정후, 공통 성분인 라우르산 아미드프로필베타인, 프로필렌글리콜, 및 향료를 첨가하고, 전체량이 100질량%가 되도록 정제수를 첨가해서, 실시예 1∼11 및 19∼32, 및 비교예 1∼10의 각 액체 피부 세정제 조성물을 얻었다. After warming the purified water to 70 ° C. to 80 ° C., dissolving the anionic surfactant of component (A), cooling to 40 ° C. or less, the cationic polymer of component (B) or the cation of the comparative component of component (B) Cellulose and polyethylene glycol as component (C) or a comparative component of component (C) were added. The said purified water used the quantity used as 95 mass % of the liquid skin cleanser composition finally obtained. After that, if the pH is less than the predetermined pH (pH10.0), potassium hydroxide, a common ingredient, is added, and after adjusting the predetermined pH to 10.0, the common ingredients, lauric acid amide propyl betaine, propylene glycol, and fragrance are added. Then, purified water was added so that the total amount was 100% by mass, and each liquid skin cleanser composition of Examples 1 to 11 and 19 to 32 and Comparative Examples 1 to 10 was obtained.
또한, 상기 각 액체 피부 세정제 조성물을 조제할 때, 교반 날개로서는 프로펠러를 사용하고, 쓰리원모터(HEIDON BL1200, 신토 가가쿠 가부시키가이샤제)를 사용해서 교반했다. 또한, pH는 pH미터(HM-30R, TOA DKK사제)를 사용하고, 25℃에서 측정했다.In addition, when preparing each said liquid skin cleanser composition, it stirred using the three-one motor (HEIDON BL1200, Shinto Chemical Co., Ltd. make) using the propeller as a stirring blade. In addition, pH was measured at 25 degreeC using the pH meter (HM-30R, made by TOA DKK).
(실시예 12∼18)(Examples 12 to 18)
하기 표 2 및 표 3에 나타내는 조성, 및 함유량의 액체 피부 세정제 조성물을 이하의 방법에 준해서 조제했다.The liquid skin cleanser composition of the composition and content shown in following Table 2 and Table 3 was prepared according to the following method.
실시예 1∼11 및 19∼32의 액체 피부 세정제 조성물의 조제에 있어서, (A)성분의 음이온성 계면활성제를 용해하고, (B)성분의 양이온성 폴리머 및 (C)성분의 폴리에틸렌글리콜을 첨가할 때에, (D)성분의 공중합체도 첨가한 것 이외는 실시예 1∼11 및 19∼32의 액체 피부 세정제 조성물의 조제 방법과 같은 방법으로 실시예 12∼18의 각 액체 피부 세정제 조성물을 얻었다.In preparing the liquid skin cleanser compositions of Examples 1 to 11 and 19 to 32, the anionic surfactant of component (A) was dissolved, and the cationic polymer of component (B) and polyethylene glycol of component (C) were added. When preparing, each liquid skin cleanser composition of Examples 12 to 18 was obtained in the same manner as in the preparation method of the liquid skin cleanser composition of Examples 1 to 11 and 19 to 32, except that the copolymer of component (D) was also added. .
얻어진 실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물은 포머 펌프 디스펜서 부착 용기[토출량 3mL, 가부시키가이샤 요시노 고교쇼제]에 충전하고, 이하의 평가에 사용했다.Each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10 obtained was filled into a container with a foamer pump dispenser (discharge amount: 3 mL, manufactured by Yoshino Kogyosho Co., Ltd.), and used for the following evaluation.
실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물에 대해서, 이하와 같이 해서 「거품 유지」, 「헹굼시의 피부의 매끄러움」, 「타올 드라이후의 피부의 탄력」, 「타올 드라이후의 피부의 당김감」, 및 「저온 안정성」을 평가 및 판정했다. 결과를 하기 표 1∼표 5에 나타냈다.Regarding each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10, as follows, "foam retention", "skin smoothness during rinsing", "skin elasticity after towel drying", "towel Skin tightness after drying" and "low-temperature stability" were evaluated and judged. The results are shown in Tables 1 to 5 below.
<거품 유지><keep foam>
전문평가자 10명이 실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물을 나일론 타올(아와스터 바디타올 소프트, 키쿠론사제)에 2푸시(약 6g) 취하고, 전신을 세정후에 「거품 유지」를 관찰하고, 하기 평가 기준에 의거해서 평가했다. 결과는 상기 전문평가자 10명의 평점 평균값을 구하고, 하기 평점 평균값의 판정 기준에 의거해 판정했다.Ten expert evaluators took 2 pushes (about 6 g) of each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10 on a nylon towel (Awaster Body Towel Soft, manufactured by Kikuron), and washed the whole body with " Foam retention" was observed and evaluated based on the following evaluation criteria. The result was determined by obtaining the average rating value of the above 10 professional raters, and based on the following evaluation criteria for the average rating value.
-「거품 유지」의 평가 기준--Evaluation criteria for "bubble retention"-
4점:신체를 다씻었을 쯤, 씻기 초반에 신체에 묻은 대부분의 거품이 남아있다4 points: By the time you finish washing your body, most of the foam on your body at the beginning of washing remains.
3점:신체를 다씻었을 쯤, 씻기 초반에 신체에 묻은 8할∼5할 정도의 거품이 남아 있다3 points: After washing the body, about 80% to 50% of the foam remaining on the body at the beginning of washing
2점:신체를 다씻었을 쯤, 씻기 초반에 신체에 묻은 2할∼4할 정도의 거품이 남아있다2 points: After washing the body, about 20% to 40% of the foam remaining on the body at the beginning of washing
1점:신체를 다씻었을 쯤, 씻기 초반에 신체에 묻은 거품이 거의 남아 있지 않다1 point: By the time the body is finished washing, almost no foam remains on the body at the beginning of washing
-「거품 유지」의 판정 기준--Judgment criteria of "foam retention"-
◎:평점 평균값이 3.5점 이상 4.0점 이하◎: The average rating is 3.5 or more and 4.0 or less
○:평점 평균값이 3.0점 이상 3.5점 미만○: The average rating value is 3.0 or more and less than 3.5
△:평점 평균값이 2.0점 이상 3.0점 미만△: Average rating value is 2.0 or more and less than 3.0
×:평점 평균값이 2.0점 미만×: The average score is less than 2.0 points
<헹굼시의 피부의 매끄러움><Skin smoothness at the time of rinsing>
전문평가자 10명이 실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물을 5푸시(약 15g) 손에 취하고, 손으로 전신을 세정후, 40℃의 온수로 헹궈냈을 때의 「헹굼시의 피부의 매끄러움」을 하기 평가 기준에 의거해서 평가했다. 결과는 상기 전문평가자 10명의 평점 평균값을 구하고, 하기 평점 평균값의 판정 기준에 의거해 판정했다.10 expert evaluators took 5 pushes (about 15 g) of each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10 in their hands, washed their whole body with their hands, and then rinsed with warm water at 40 ° C. The smoothness of the skin of the city" was evaluated based on the following evaluation criteria. The result was determined by obtaining the average rating value of the above 10 professional raters, and based on the following evaluation criteria for the average rating value.
-「헹굼시의 피부의 매끄러움」의 평가 기준--Evaluation criteria of "skin smoothness at the time of rinsing"-
4점:피부에 매끄러움을 강하게 느낀다4 points: I strongly feel the smoothness on the skin
3점:피부에 매끄러움을 느낀다3 points: I feel smoothness on the skin
2점:피부에 매끄러움을 다소 느낀다2 points: Somewhat smoothness is felt on the skin
1점:피부에 매끄러움을 느끼지 않는다1 point: I do not feel smoothness on skin
-「헹굼시의 피부의 매끄러움」의 판정 기준--Judgment criteria of "skin smoothness at the time of rinsing"-
◎:평점 평균값이 3.5점 이상 4.0점 이하◎: The average rating is 3.5 or more and 4.0 or less
○:평점 평균값이 3.0점 이상 3.5점 미만○: The average rating value is 3.0 or more and less than 3.5
△:평점 평균값이 2.0점 이상 3.0점 미만△: Average rating value is 2.0 or more and less than 3.0
×:평점 평균값이 2.0점 미만×: The average score is less than 2.0 points
<타올 드라이후의 피부의 탄력><Skin elasticity after towel drying>
전문평가자 10명이 실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물을 5푸시(약 15g) 손에 취하고, 손으로 전신을 세정후, 40℃의 온수로 헹궈내고, 타올 드라이했다. 그 후, 24℃의 항온실에서 30분간 안정으로 한 후, 「타올 드라이후의 피부의 탄력」을 하기 평가 기준에 의거해서 평가했다. 결과는 상기 전문평가자 10명의 평점 평균값을 구하고, 하기 평점 평균값의 판정 기준에 의거해 판정했다.10 expert evaluators took 5 pushes (about 15 g) of each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10, washed the whole body with their hands, rinsed with warm water at 40 ° C, and towel dried. . Thereafter, after stabilizing for 30 minutes in a constant temperature room at 24°C, "skin elasticity after towel drying" was evaluated based on the following evaluation criteria. The result was determined by obtaining the average rating value of the above 10 professional raters, and based on the following evaluation criteria for the average rating value.
-「타올 드라이후의 피부의 탄력」의 평가 기준--Evaluation criteria for "skin elasticity after towel drying"-
4점:손바닥으로 전완을 눌렀을 때에 피부가 움직이는 느낌을 강하게 느낀다4 points: Strong feeling of skin movement when pressing the forearm with the palm of the hand
3점:손바닥으로 전완을 눌렀을 때에 피부가 움직이는 느낌을 느낀다3 points: Feeling the skin move when pressing the forearm with the palm of the hand
2점:손바닥으로 전완을 눌렀을 때에 피부가 움직이는 느낌을 다소 느낀다2 points: When the forearm is pressed with the palm of the hand, a feeling of movement of the skin is slightly felt.
1점:손바닥으로 전완을 눌렀을 때에 피부가 움직이는 느낌을 느끼지 않는다1 point: When the forearm is pressed with the palm, the skin does not feel the movement.
-「타올 드라이후의 피부의 탄력」의 판정 기준--Judgment criteria for "skin elasticity after towel drying"-
◎:평점 평균값이 3.5점 이상 4.0점 이하◎: The average rating is 3.5 or more and 4.0 or less
○:평점 평균값이 3.0점 이상 3.5점 미만○: The average rating value is 3.0 or more and less than 3.5
△:평점 평균값이 2.0점 이상 3.0점 미만△: Average rating value is 2.0 or more and less than 3.0
×:평점 평균값이 2.0점 미만×: average score is less than 2.0 points
<타올 드라이후의 피부의 당김감><Skin tightness after towel drying>
전문평가자 10명이 실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물을 5푸시(약 15g) 손에 취하고, 손으로 전신을 세정후, 40℃의 온수로 헹궈내고, 타올 드라이했다. 그 후, 24℃의 항온실에서 30분간 안정으로 한 후, 「타올 드라이후의 피부의 당김감」을 하기 평가 기준에 의거해서 평가했다. 결과는 상기 전문평가자 10명의 평점 평균값을 구하고, 하기 평점 평균값의 판정 기준에 의거해 판정했다.10 expert evaluators took 5 pushes (about 15 g) of each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10, washed the whole body with their hands, rinsed with warm water at 40 ° C, and towel dried. . Thereafter, after stabilizing for 30 minutes in a constant temperature room at 24°C, "skin tension after towel drying" was evaluated based on the following evaluation criteria. The result was determined by obtaining the average rating value of the above 10 professional raters and based on the following criteria for rating average value.
-「타올 드라이후의 피부의 당김감」의 평가 기준--Evaluation Criteria for "Skin Tightness After Towel Drying"-
4점: 전혀 피부의 당김감을 느끼지 않는다4 points: I do not feel any tightening of the skin at all.
3점: 다소 피부의 당김감을 느낀다3 points: I feel a slight tightening of the skin
2점: 상당히 피부의 당김감을 느낀다2 points: Feel the tightening of the skin considerably
1점: 매우 피부의 당김감을 느낀다1 point: feel very tight skin
-「타올 드라이후의 피부의 당김감」의 판정 기준--Judgment criteria for "skin tightness after towel drying"-
◎:평점 평균값이 3.5점 이상 4.0점 이하◎: The average rating is 3.5 or more and 4.0 or less
○:평점 평균값이 3.0점 이상 3.5점 미만○: The average rating value is 3.0 or more and less than 3.5
△:평점 평균값이 2.0점 이상 3.0점 미만△: Average rating value is 2.0 or more and less than 3.0
×:평점 평균값이 2.0점 미만×: The average score is less than 2.0 points
<저온 안정성><Low Temperature Stability>
실시예 1∼32 및 비교예 1∼10의 각 액체 피부 세정제 조성물을 약 50g, 원기둥형의 투명 유리병(직경 4cm, 높이 7.5cm)에 넣고, -5℃의 항온조에서 2주간 보존했다. 전문 패널리스트가 2주일 보존후의 액체 피부 세정제 조성물의 석출물의 생성 상태를 육안으로 관찰하고, 하기 평가 기준에 의거해서 평가했다.About 50 g of each liquid skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 10 was placed in a cylindrical transparent glass bottle (diameter 4 cm, height 7.5 cm), and stored in a -5°C thermostat for 2 weeks. A professional panelist visually observed the formation state of the precipitate of the liquid skin cleanser composition after storage for 2 weeks, and evaluated based on the following evaluation criteria.
-「저온 안정성」의 판정 기준--Judgment criteria of "low-temperature stability"-
◎:2주일 이내에 결정 또는 고체의 석출을 전혀 확인하지 못함◎: No precipitation of crystals or solids was confirmed within 2 weeks
○:2주일 이내에 결정 또는 고체의 석출을 거의 확인하지 못함(상품가치상, 문제 없음)○: Precipitation of crystals or solids was hardly confirmed within 2 weeks (no problem in terms of product value)
×:2주일 이내에 다량의 결정 또는 고체의 석출을 확인함×: Confirmation of precipitation of a large amount of crystals or solids within 2 weeks
실시예 1∼32 및 비교예 1∼10에서 사용한 각 성분의 상세에 대해서, 하기 표 6에 나타낸다.Details of each component used in Examples 1 to 32 and Comparative Examples 1 to 10 are shown in Table 6 below.
※1:라우르산 칼륨은 라우르산(NAA-122, NOF CORPORATION제)을 수산화 칼륨(아사히가라스 가부시키가이샤제, 액체 가성 칼리)으로 중화시켜서 조제한 것을 사용했다.※1: Potassium laurate was prepared by neutralizing lauric acid (NAA-122, manufactured by NOF CORPORATION) with potassium hydroxide (manufactured by Asahi Glass Co., Ltd., liquid caustic potash).
※2:미리스틴산 칼륨은 미리스틴산(NAA-142, NOF CORPORATION제)을 수산화 칼륨(아사히가라스 가부시키가이샤제, 액체 가성 칼리)으로 중화시켜서 조제한 것을 사용했다.※2: Potassium myristate was prepared by neutralizing myristic acid (NAA-142, manufactured by NOF CORPORATION) with potassium hydroxide (manufactured by Asahi Glass Co., Ltd., liquid caustic potash).
※3:팔미트산 칼륨은 팔미트산(NAA-160, NOF CORPORATION제)을 수산화 칼륨(액체 가성 칼리, 아사히가라스 가부시키가이샤제)으로 중화시켜서 조제한 것을 사용했다.*3: Potassium palmitate was prepared by neutralizing palmitic acid (NAA-160, manufactured by NOF CORPORATION) with potassium hydroxide (liquid caustic potash, manufactured by Asahi Glass Co., Ltd.).
※4:스테아르산 칼륨은 스테아르산(NAA-180, NOF CORPORATION제)을 수산화 칼륨(액체 가성 칼리, 아사히가라스 가부시키가이샤제)으로 중화시켜서 조제한 것을 사용했다.*4: Potassium stearate was prepared by neutralizing stearic acid (NAA-180, manufactured by NOF CORPORATION) with potassium hydroxide (liquid caustic potash, manufactured by Asahi Glass Co., Ltd.).
상기 액체 피부 세정제 조성물은 포머 용기에 적합하게 사용할 수 있고, 거품 유지가 우수하고, 타올 드라이후의 피부에 당김감을 느끼지 않고, 헹굼시의 피부의 매끄러움 및 타올 드라이후의 피부의 탄력이 양호하며, 또한 저온 안정성이 우수하므로, 예를 들면, 바디 샴푸, 바디 소프, 세안폼, 핸드 소프, 거품 핸드 소프, 클렌징폼, 클렌저 등에 사용할 수 있고, 특히, 나일론 타올이나 면 타올 등의 세정 용구를 사용해서 거품을 내서 사용하는 바디 소프에 적합하게 사용할 수 있다.The liquid skin cleanser composition can be suitably used in a foamer container, has excellent foam retention, does not feel tight on the skin after towel drying, has good skin smoothness during rinsing and good skin elasticity after towel drying, In addition, since it has excellent low-temperature stability, it can be used, for example, in body shampoo, body soap, face wash foam, hand soap, foam hand soap, cleansing foam, cleanser, etc. It can be used suitably for body soap that is used after making bubbles.
Claims (4)
(B)염화디메틸디알릴암모늄 중합체 및 염화디메틸디알릴암모늄-아크릴산 공중합체로부터 선택되는 적어도 1종의 양이온성 폴리머와,
(C)평균 분자량이 190∼630인 폴리에틸렌글리콜을 함유하고,
상기 (A)성분의 함유량이 10질량%∼25질량%이며,
상기 (B)성분의 염화디메틸디알릴암모늄-아크릴산 공중합체에 있어서의 염화디메틸디알릴암모늄으로부터 유래하는 구조단위의 몰비가 40몰% 이상이며,
상기 (C)성분의 함유량에 대한 상기 (A)성분의 함유량의 질량비[(A)/(C)]가 15∼100이며,
포머 용기에 충전되어서 이루어지는 것을 특징으로 하는 액체 피부 세정제 조성물.(A) (a1) an anionic surfactant containing at least one selected from palmitate and (a2) stearate;
(B) at least one cationic polymer selected from dimethyldiallylammonium chloride polymer and dimethyldiallylammonium chloride-acrylic acid copolymer;
(C) containing polyethylene glycol having an average molecular weight of 190 to 630;
The content of the component (A) is 10% by mass to 25% by mass,
The molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer of the component (B) is 40 mol% or more,
The mass ratio of the content of the component (A) to the content of the component (C) [(A) / (C)] is 15 to 100,
A liquid skin cleanser composition characterized in that it is filled in a foamer container.
(D)하기 일반식(1)으로 나타내어지는 공중합체를 더 함유하는 액체 피부 세정제 조성물.
단, 상기 일반식(1) 중, n, m, 및 z는 각 구조단위의 몰비(몰%)를 나타내고, n+m+z=100이며, 상기 n은 0∼34, 상기 m은 24∼31, 상기 z는 35∼76이다.According to claim 1,
(D) A liquid skin cleanser composition further containing a copolymer represented by the following general formula (1).
However, in the general formula (1), n, m, and z represent the molar ratio (mol%) of each structural unit, n + m + z = 100, the n is 0 to 34, the m is 24 to 31, said z is 35-76.
상기 (A)성분의 함유량에 대한 상기 (a1)팔미트산염과 상기 (a2)스테아르산염의 합계 함유량의 질량비[((a1)+(a2))/(A)]가 0.1∼0.5인 액체 피부 세정제 조성물.According to claim 1 or 2,
Liquid skin whose mass ratio [((a1)+(a2))/(A)] of the total content of the (a1) palmitate and the (a2) stearate to the content of the component (A) is 0.1 to 0.5 detergent composition.
상기 (B)성분의 함유량이 0.2질량%∼0.8질량%이며,
상기 (C)성분의 함유량이 0.2질량%∼0.8질량%이며,
상기 (D)성분의 함유량이 0.05질량%∼0.3질량%인 액체 피부 세정제 조성물.According to any one of claims 1 to 3,
The content of the component (B) is 0.2% by mass to 0.8% by mass,
The content of the component (C) is 0.2% by mass to 0.8% by mass,
The liquid skin cleanser composition whose content of the said (D) component is 0.05 mass % - 0.3 mass %.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2021-100195 | 2021-06-16 | ||
JP2021100195A JP7349473B2 (en) | 2021-06-16 | 2021-06-16 | liquid skin cleanser composition |
PCT/JP2022/005716 WO2022264507A1 (en) | 2021-06-16 | 2022-02-14 | Liquid skin cleanser composition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230116069A true KR20230116069A (en) | 2023-08-03 |
KR102644492B1 KR102644492B1 (en) | 2024-03-08 |
Family
ID=84526050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020237024676A KR102644492B1 (en) | 2021-06-16 | 2022-02-14 | Liquid skin cleanser composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7349473B2 (en) |
KR (1) | KR102644492B1 (en) |
CN (1) | CN117279611A (en) |
WO (1) | WO2022264507A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004262838A (en) | 2003-02-28 | 2004-09-24 | Kao Corp | Skin cleaner composition |
JP2006193467A (en) * | 2005-01-13 | 2006-07-27 | Shiseido Co Ltd | Skin detergent composition |
JP2014208633A (en) | 2013-03-29 | 2014-11-06 | ライオン株式会社 | Skin detergent composition in foamer container |
KR20190015699A (en) * | 2016-05-31 | 2019-02-14 | 라이온 가부시키가이샤 | Liquid skin cleanser composition |
WO2019097950A1 (en) | 2017-11-16 | 2019-05-23 | ライオン株式会社 | Liquid skin cleanser composition |
JP6764413B2 (en) * | 2015-09-18 | 2020-09-30 | ライオン株式会社 | Skin cleanser composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6287835B2 (en) * | 2012-06-29 | 2018-03-07 | ライオン株式会社 | Liquid skin cleanser products |
WO2016103892A1 (en) * | 2014-12-25 | 2016-06-30 | ライオン株式会社 | Liquid skin cleansing agent composition |
-
2021
- 2021-06-16 JP JP2021100195A patent/JP7349473B2/en active Active
-
2022
- 2022-02-14 WO PCT/JP2022/005716 patent/WO2022264507A1/en active Application Filing
- 2022-02-14 KR KR1020237024676A patent/KR102644492B1/en active IP Right Grant
- 2022-02-14 CN CN202280033325.2A patent/CN117279611A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004262838A (en) | 2003-02-28 | 2004-09-24 | Kao Corp | Skin cleaner composition |
JP2006193467A (en) * | 2005-01-13 | 2006-07-27 | Shiseido Co Ltd | Skin detergent composition |
JP2014208633A (en) | 2013-03-29 | 2014-11-06 | ライオン株式会社 | Skin detergent composition in foamer container |
JP6764413B2 (en) * | 2015-09-18 | 2020-09-30 | ライオン株式会社 | Skin cleanser composition |
KR20190015699A (en) * | 2016-05-31 | 2019-02-14 | 라이온 가부시키가이샤 | Liquid skin cleanser composition |
WO2019097950A1 (en) | 2017-11-16 | 2019-05-23 | ライオン株式会社 | Liquid skin cleanser composition |
Also Published As
Publication number | Publication date |
---|---|
JP7349473B2 (en) | 2023-09-22 |
JP2022191760A (en) | 2022-12-28 |
WO2022264507A1 (en) | 2022-12-22 |
CN117279611A (en) | 2023-12-22 |
KR102644492B1 (en) | 2024-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102144496B1 (en) | Liquid skin cleanser product | |
JP7291009B2 (en) | Liquid skin cleanser composition | |
JP2017218383A (en) | Cleaning agent composition | |
JP7236314B2 (en) | Liquid skin cleanser composition | |
JP7204664B2 (en) | Liquid skin cleanser composition | |
JP6654990B2 (en) | Liquid skin cleanser composition | |
JP7286526B2 (en) | Liquid skin cleanser composition | |
KR102644492B1 (en) | Liquid skin cleanser composition | |
JP7247710B2 (en) | personal care composition | |
JP2000143497A (en) | Creamy detergent composition | |
JP6831747B2 (en) | Liquid skin cleanser composition | |
WO2017208524A1 (en) | Liquid skin cleanser composition | |
JP2017214327A (en) | Liquid cleanser composition | |
KR20240026877A (en) | Liquid skin cleanser composition | |
JP6951916B2 (en) | Liquid skin cleanser composition | |
JP2023062607A (en) | Skin cleansing composition | |
JP2018203700A (en) | Liquid skin cleansing composition | |
JP7250042B2 (en) | Liquid skin cleanser composition | |
KR20230126700A (en) | liquid skin cleanser composition | |
JP2023177999A (en) | liquid skin cleanser composition | |
JP2022178940A (en) | Skin detergent composition | |
JP2023088105A (en) | Liquid skin cleansing composition | |
JP2023128960A (en) | Skin detergent composition | |
JP2023152321A (en) | Skin cleanser composition | |
KR20240025496A (en) | Skin Cleanser Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |